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ABSTRACT
DETRIMENTAL EFFECTS OF INACTIVITY ON INSULIN ACTION
MAY 2009
BROOKE R. STEPHENS, B.S. CREIGHTON UNIVERSITY
M.S., BALL STATE UNIVERSITY
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Barry Braun
Inactivity reduces insulin action. Energy surplus causes similar reductions to
insulin action. Unless energy intake is reduced to match low energy expenditure during
inactivity, a concurrent energy surplus may account for the lower insulin action. This
study evaluated the effect of inactivity (sitting) with and without energy surplus on
insulin action. Fourteen young (26.1 ± 4.5 years (M ± SD)), lean (23.7 ± 7.1% fat), fit
(VO2peak = 49.1 ± 3.3 ml•kg-1•min-1) men (n=7) and women (n=7) completed each of 3,
24-hour conditions: an active condition (i.e. high energy expenditure with energy intake
matched to expenditure) = ACTIV; 2) reduced energy expenditure (inactivity) with no
reduction in energy intake (i.e. energy surplus) = INACTIV; 3) inactivity with energy
intake reduced to match low energy expenditure = INACTIV LO-CAL. Insulin action
was measured during a glucose infusion the following morning. Data were analyzed
using linear mixed-effects models with planned contrasts. Compared to ACTIV, insulin
action, defined as whole-body rate of glucose disappearance (Rd) scaled to steady-state
plasma insulin, was reduced 39% in INACTIV (p < 0.001) and by 18% in INACTIV LOCAL (p = 0.07). Insulin action was also higher in INACTIV LO-CAL compared to
INACTIV (p =0.04). These results suggest that 1 day of sitting elicits large reductions in
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insulin action. Energy surplus accounts for half of the decline in insulin action,
suggesting other factors are involved in the metabolic response to inactivity.
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CHAPTER 1
INTRODUCTION

It is well-established that structured exercise confers benefits to metabolic health
and reduces risk for disease (29, 74, 95, 96, 101). Limited epidemiological data suggest
that low-intensity activities of daily living, such as standing, ambulation, etc. (i.e. activity
not defined as exercise), are also beneficial to metabolic health (59, 70). However, the
relative importance of non-exercise physical activity, versus structured exercise, on
health is less understood. Physical inactivity (i.e. considerable reductions in ambulation
and standing), imposed by hindlimb suspension in rodents or bed rest in humans, clearly
reduces insulin action (32, 90, 100, 119, 131, 133, 137) and impairs lipid metabolism (10,
14, 100).
Although a recent study examined the metabolic response to large reductions in
daily walking (e.g. from10,000 steps/d to < 1500 steps/d) (114), no published studies
have focused on the direct effects of more typical sedentary behaviors involving sitting
(e.g. watching television, working on a computer, etc.). Understanding the metabolic
impact of prolonged sitting has real-world relevance (54) since many people spend
considerable amounts of time engaged in sedentary behaviors involving sitting (17, 97).
The underlying mechanism(s) for the impaired insulin action and lipid
metabolism in response to physical inactivity are not well-characterized. A previously
unexplored mechanism (i.e. energy imbalance) may be involved in the inactivity-induced
decline in metabolic health. Less standing and ambulation reduces energy expenditure
and leads to energy surplus unless energy intake is reduced to match the low expenditure.
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Energy surplus independently reduces insulin action (4, 113) and impairs lipid
metabolism (103). Therefore, the effects attributed to inactivity may actually be
mediated by a concurrent energy surplus. However, no studies have determined the
discrete effect of inactivity itself from the confounding impact of energy surplus by
lowering energy intake to match the lower energy expenditure. Therefore, this study was
designed to: 1) evaluate the metabolic impact of inactivity (sitting) and 2) to determine
whether inactivity-induced declines in insulin action and lipid metabolism are attributable
to energy surplus.

1.1

Specific Aims and hypotheses
To test the specific aims of this study, subjects completed 3 different conditions:

1) an active condition (i.e. high energy expenditure with energy intake matched to
expenditure) = ACTIV; 2) reduced energy expenditure (inactivity) without a concomitant
reduction in energy intake (energy intake > expenditure, i.e. energy surplus) = INACTIV;
3) inactivity with energy intake reduced to match the low expenditure = INACTIV LOCAL. Specific aims and hypotheses of the study are presented below.
Aim 1: Determine the effect of 24 hours of inactivity, with no change to energy
intake, on insulin-mediated glucose uptake (insulin action). We expected that inactivity
would significantly reduce insulin-mediated glucose disposal (i.e. insulin action) relative
to the active condition (i.e. INACTIV < ACTIV).
Aim 2: Determine the effect of 24 hours of inactivity, without the potential
confounding effect of energy surplus, on insulin action. We expected that reducing
energy intake to match low expenditure would attenuate, but not completely prevent, the
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inactivity-induced decline in insulin action (i.e. INACTIV < INACTIV LO-CAL <
ACTIV).
Aim 3: To determine the effect of inactivity on lipid metabolism. We expected
that inactivity, with no change in energy intake, would impair: fasting lipid oxidation,
fasting free fatty acid and triacylglycerol concentrations, and insulin-mediated
suppression of lipolysis. However, we expected that reducing energy intake to match low
expenditure would attenuate impairments to lipid metabolism relative to the active
condition (i.e. INACTIV < INACTIV LO-CAL < ACTIV).

1.2

Significance
The aims of this study are to understand the metabolic response to 24 hours of

sitting and to determine whether the deleterious effects of inactivity on that response are
at least partially attributable to energy surplus. Results from this study will provide
insights into factors that reduce insulin action and impair lipid metabolism following
inactivity. Knowledge gained from this study is critically important to tailor appropriate
public health recommendations to oppose the rapid and potentially frequent declines in
metabolic health that result from sitting too much.
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CHAPTER 2
REVIEW OF LITERATURE

2.1

Associations of physical activity and health
It is well-established that exercise improves cardiometabolic health and reduces

risk of disease (29, 74, 95, 96, 101). Epidemiological investigations have repeatedly
demonstrated a negative association between physical activity level and/or fitness and allcause mortality (13), cardiovascular mortality (13, 38, 104, 105), and incidence of type 2
diabetes (13, 38, 64, 95, 104, 105) independent of age or obesity status. Data from crosssectional observations have shown habitually active individuals are more insulin sensitive
(30, 102, 126), have elevated HDL cholesterol (66, 141, 151, 152), reduced LDL
cholesterol and triacylglycerol levels (141, 151, 152), have a greater capacity to oxidize
fatty acids (126) and exhibit enhanced triacylglycerol clearance (141) compared to their
less active counterparts.
Maintaining the health benefits of exercise requires repeated bouts of sufficient
frequency, intensity and duration (108, 132). Experimental data in both humans and
rodents clearly indicate that the benefits of exercise are lost rapidly following exercise
cessation. Exercise-induced increases in GLUT-4 protein and insulin-stimulated glucose
uptake are completely reversed in isolated rat muscle 53 hours following cessation of
running (84) or 40 hours after cessation of swimming (68). Insulin action, as assessed by
an oral glucose tolerance test, is rapidly reduced in endurance-trained individuals upon
cessation of exercise for 7-14 days (3, 62, 69). Glucose disposal rate assessed during a
euglycemic-hyperinsulinemic clamp was reduced by 23% following 10 days without
exercise in trained men (79). Similarly, 5 days of detraining in physically-trained
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subjects elicited a 23% increase in the insulin concentration required to elicit 50% of
maximal glucose disposal (102), indicative of reduced insulin sensitivity. Further,
Burstein et al. (21) observed a significant decrease in glucose clearance rate in athletes 60
hours after the last exercise bout. Thus, exercise-enhanced insulin action is rapidly
reversed by cessation of exercise in as little as several days.
A number of observational studies also suggest that, over time, reduced physical
activity levels can lead to insulin resistance and type 2 diabetes and mortality associated
with the metabolic syndrome (51, 82, 98), which is independent of age (147) and obesity
status (20, 43, 64, 72, 91, 93, 95, 96, 147). Powell and Blair (120) estimated that 21% of
deaths related to diabetes in 1988 were attributable to insufficient physical activity (less
than 30 min/d or fewer than 5 d/wk of light or moderate physical activities). Thus,
experimental and epidemiological evidence suggest reduced physical activity associated
with exercise has deleterious effects on metabolic processes that over time increase the
risk for disease (17). This knowledge has prompted current public health guidelines
promoting at least 150 min/wk of moderate-intensity or 60 min/wk of vigorous-intensity
physical activity to optimize metabolic health and reduce disease risk (57).

2.2

Impact of sedentary behavior and non-exercise activity on disease risk
Sedentary behavior associated with sitting and non-exercise activity involving

standing (e.g. housework, stair-climbing, walking at home or work, etc.) also have effects
on cardiometabolic health (54). Data from a number of epidemiological investigations
indicate that the physical activity dose-response curve is steep with a significant increase
in risk of disease and mortality in those individuals who are the least active (Fig. 2.1) (54,
56).
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Figure 2.1 Relationship between physical activity and the risk for coronary heart
disease/death (adapted from Haskell (56)).
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In a recent meta-analysis of 23 studies, there was a 1.31-1.45 increase in risk of diabetes
for sedentary individuals compared with their active counterparts (19). Powell and Blair
(120) estimated that approximately 12% of deaths from diabetes in 1988 could be
attributed to a sedentary lifestyle (defined as no leisure-time physical activity from selfreport measures). Authors of a more recent prospective study of male physicians
concluded that at least 25% of the incidence of type 2 diabetes could be attributable to a
sedentary lifestyle (95). However, these associations are limited by different
classifications and measurement of sedentary behavior. Until recently, many studies
have not assessed time spent in sedentary behavior (e.g. via questionnaires on TV
watching). Instead, low levels of self-reported leisure-time activities (i.e. lack of physical
activity) are often used as a proxy measure of sedentary behavior. Thus, most
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epidemiological studies have failed to distinguish the effect of sedentary behavior versus
lack of physical activity. Recent data points to the importance of making the distinction
between participation in physical activity and time spent in sedentary behaviors to
provide independent measures of the activity spectrum (41, 83). Recently, several studies
have suggested that sedentary behavior associated with sitting, distinguished from lack of
physical activity (i.e. low levels of self-reported leisure-time activities), may have an
independent effect on aspects of cardiovascular and metabolic health (9, 36, 37, 41, 71,
128). Sedentary behavior assessed by self-reported time spent watching television was
positively associated with triacylglycerol levels and other risk factors for cardiovascular
disease (83) and blood glucose levels in adults (35, 59, 83), independent of adiposity and
time spent in physical activity (35, 37). Hu et al. (71) reported that for every 2 hr/d
increase in television viewing time, risk of diabetes was increased by 14%. A recent
study using more objective, accelerometer-based measures of physical activity and
sedentary behavior reported a significant, positive association between sedentary time
and 2-hour plasma glucose concentration following an oral glucose challenge, which was
independent of age, sex, and waist circumference (59). It should be noted that television
viewing time was taken to be representative of overall sedentary behavior in the majority
of these studies. Although television viewing time has been shown to be most strongly
associated with risk of type 2 diabetes compared to several other sedentary behaviors (i.e.
sitting at work or other sitting) (71), television-viewing time constitutes only one
component of sedentary behavior and it remains unknown the extent to which television
viewing is representative of overall sedentary behavior (35). Nonetheless, these studies
strongly suggest sedentary behavior involving prolonged sitting may be an important
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modifier of metabolic health independent of obesity status and may mediate effects on
metabolic function that are distinct from those of physical activity (35).
Moreover, these studies suggest that a significant reduction in risk of insulin
resistance and type 2 diabetes can be gained by slight rightward shifts along the physical
activity continuum (Fig. 2.1), highlighting the importance of daily non-exercise physical
activity on cardiometabolic health. For instance, risk for development of type 2 diabetes
was found to be highest in individuals who accumulated less than 500 kcals of activity
per week; for each 500 kcal increment in weekly energy expenditure associated not only
with sports activity, but also with walking and stair climbing, risk for diabetes was
reduced by 6% (96). This association remained significant even after adjusting for
obesity status, hypertension, and family history of type 2 diabetes (96). Similarly, a more
recent study found that while brisk walking reduced the risk of diabetes by 34% for each
1 hr/d increment, even the activity associated with standing or puttering at home reduced
diabetes risk by 12% for each 2 hr/d increment (71). Using accelerometry to objectively
measure activity, Healy et al. (59) demonstrated a significant effect of low-intensity
activity on 2-hour postprandial glucose concentration independent of time spent in
moderate-vigorous activity.
Taken together, epidemiological evidence suggests that mortality and risk of
disease cannot simply be ascribed to reductions in exercise. This underscores the
significance of an inactivity physiology paradigm recently proposed by Hamilton and
colleagues (53, 54) that sitting more and performing less non-exercise activity should be
regarded as classes of behavior distinct from exercise that have independent effects on
risk for disease (17). This paradigm emphasizes the importance of maintaining daily
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non-exercise activity, which has real world relevance because for most individuals, the
contribution of non-exercise activity to total daily energy expenditure is much greater
compared to exercise (54, 150). Viewed in this context, understanding the underlying
processes and mechanisms responsive to physical inactivity (i.e. reductions in contractile
activity associated with standing, and ambulation) that promote disease is important (17).
Whereas the metabolic adaptations to different amounts and types of physical activity
have been relatively well-characterized, much less is understood regarding the response
to increasing inactivity. It may be erroneous to assume that the adaptations to physical
inactivity are merely opposite to the adaptations to physical activity (17, 54). In fact, in
several well-controlled studies performed in rodents, reduced standing and ambulation
had a much larger negative effect on lipoprotein metabolism than the positive effect of
adding vigorous exercise training on top of normal daily activity levels (10, 54, 155). In
addition, the molecular mechanisms underlying these changes in lipoprotein metabolism
were distinctly different between inactivity and exercise training (10, 54, 155).
Limited experimental studies in both animals and humans have investigated the
metabolic response to short-term and prolonged inactivity. Because the main focus of the
present proposal is on the inactivity-induced changes in insulin action and glucose and
lipid metabolism, the following review of the available literature is focused on the effects
of inactivity on these metabolic parameters.

2.3

Experimental data in rodents and humans
One of the first studies to highlight the importance of standing and postural

control was performed in mice whose hindlimbs were immobilized with plaster casts to
significantly reduce contractile activity (131). In as little as 24 hours following
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immobilization, insulin-stimulated glucose uptake and glycogen synthesis was
significantly impaired in isolated soleus muscle (131). Similarly, hindlimb
immobilization for 42-48 hours in rats reduced maximum insulin-stimulated glucose
transport by 42% in isolated skeletal muscle (119). Thus, these studies provide direct
evidence that insulin action can be rapidly reduced in response to inactivity in rodents.
Most of the available information in humans on the effects of inactivity (i.e.
restriction of standing and ambulation), distinct from detraining (i.e. exercise restriction),
comes from bed-rest studies with or without head-down tilt to mimic the effects of antigravity. Significant increases in fasting insulin concentrations were observed after bed
rest (1, 8, 137, 144), suggesting a decrease in insulin action, although this has not been a
consistent finding (32, 90, 116). While Acheson et al. (1) observed a significant increase
in fasting insulin concentrations after 3 days of head-down bed rest, there was no change
in fasting levels of this hormone after 3 days of bed rest in the study by Lipman et al.
(90). In young, physically-active males, Stuart et al. (137) observed a 44% increase in
fasting insulin concentrations after just 6 days of bed rest, whereas other studies
employing similar (100) or more sustained (i.e. 2 weeks) bed rest protocols reported no
change in fasting insulin levels (32, 116). In contrast, Bergouignan et al. (8) reported a
22% increase in fasting insulin concentrations after 1 month of bed rest in women. A
more consistent finding in the literature, however, is impaired glucose tolerance and
increased insulin response to an oral glucose load as a result of sustained bed rest in
healthy subjects (14, 32, 116, 137). Both outcomes are indicative of reduced insulin
action, which is usually attributed to a decreased peripheral glucose uptake (90, 100,
137).
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Other studies using more direct assessments of insulin action support the finding
of an inactivity-induced impairment in insulin action. One of the earliest studies reported
a reduction in peripheral glucose uptake during a glucose infusion in as little as 3 days of
bed rest in males (90).

Further declines in peripheral glucose uptake were observed

after an additional 11 days of bed rest (total 14 days) from 82% of control at 3 days to
56% of control after 14 days (90). Insulin infusion after bed rest also resulted in a
smaller decrease in plasma glucose compared to control, further suggesting a reduction in
insulin action following inactivity (90). Several studies employing the glucose clamp
also report significant reductions in whole-body glucose uptake following 7 days of bed
rest in men (100, 137).
While bed-rest studies have provided important information on the direct effects
of restricted contractile activity on metabolic processes, this model has limited
applicability for the majority of the general population who are not bed-ridden (54).
Further, data from prolonged bed rest studies with head-down tilt may be confounded by
shifts in fluid distribution, muscle atrophy, orthostatic intolerance, etc. (54).
Very few studies, however, have investigated the effects of non bed-rest inactivity
models in humans. The limited data available support the general finding reported in bed
rest studies that inactivity reduces insulin action. In a study utilizing 7 days of single leg
casting to limit ambulatory activity, Richter et al. (125) observed reduced insulinstimulated glucose uptake in the vastus lateralis of the casted relative to the non-casted
leg. Compared to bed-rest induced inactivity, this model reduced insulin-stimulated
glucose uptake to a lesser extent, which may be reflective of continued (albeit restricted)
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muscle activity during ambulatory leg casting and/or less blunting of leg blood flow
(100).
Limited data also point to the deleterious effects of significant reductions in nonexercise activity (e.g. standing, ambulation, and other activities of daily living).
Recently, Olsen et al. (114) examined the metabolic effects of reduced daily steps (from
10,000/day to 1500/day) for 2 weeks in healthy, free-living, non-exercising men.
Compared to baseline, insulin area under the curve in response to an oral glucose
challenge was increased 57%, indicative of significantly reduced insulin action.
Experimental reductions in ambulation and standing via prolonged sitting also impair
insulin action. Compared to an active condition (i.e. high non-exercise physical activity)
in which total sitting time was limited to less than 10 minutes per hour, sixteen hours of
sitting resulted in a 30% reduction in insulin action as assessed by an oral glucose
challenge (Hamilton and colleagues, unpublished observations). In summary, select nonbed rest inactivity paradigms in humans support the general finding of significant
declines in insulin action following reductions in ambulation, standing, or other nonexercise activities.

2.4

Differential effects of inactivity in adipose tissue, liver, and skeletal muscle
It is likely that skeletal muscle accounts for the majority of the physical inactivity-

induced decline in whole-body insulin action (84) since skeletal muscle accounts for 7595% of insulin-stimulated glucose disposal in humans (6). Additionally, in isolated rat
muscle, insulin-stimulated glucose uptake is significantly reduced after exercise cessation
in as little as 40-90 hours after the last exercise bout (68, 75, 124). However, declines in
liver (hepatic) insulin sensitivity may also contribute to reductions in whole-body insulin
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action following inactivity. In addition to reduced skeletal muscle insulin sensitivity,
Blanc et al. (14) observed less suppression of hepatic glucose production following 7
days of bed rest in women, suggesting impaired hepatic insulin sensitivity (14).
However, no impairment in hepatic insulin sensitivity was observed in men in response to
a similar inactivity protocol (14, 100, 137), suggesting potential sex differences in the
physiological response to inactivity. Reduced adipose tissue insulin sensitivity has also
been observed in response to inactivity. Mikines et al. (100) observed similar reductions
in plasma free fatty acid and glycerol concentrations during a glucose infusion despite
higher insulin concentrations following 7 days of bed rest indicative of impaired insulin
suppression of lipolysis. In summary, reduced skeletal muscle insulin action likely
accounts for much of the inactivity-induced decline in whole-body insulin action, but
hepatic and adipose tissue insulin sensitivity may also be reduced.

2.5

Effect of physical inactivity on substrate metabolism
The ability to shift from oxidizing predominantly fat during fasting conditions and

increase glucose oxidation and suppress lipolysis in response to insulin stimulation
characterizes the metabolically healthy state, termed metabolic flexibility. In contrast,
metabolic inflexibility is characterized by low fat oxidation during fasting conditions and
impaired insulin-stimulated non-oxidative and oxidative glucose disposal. Originally,
metabolic flexibility and inflexibility referred to substrate use profiles observed in
skeletal muscle of lean and obese individuals (76). However, because skeletal muscle
strongly influences whole-body metabolism, these terms can also be used to characterize
whole-body substrate metabolism (136).
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A number of reports suggest that inactivity is associated with a substrate use
profile characteristic of metabolic inflexibility. In mice, hindlimb immobilization
significantly reduced insulin-stimulated glycogen synthesis and glucose oxidation in
isolated soleus muscle (131). Hindlimb unloading for 9 days reduced the capacity to
oxidize long-chain fatty acids by 37% and increased reliance on carbohydrate utilization
(5), supporting the hypothesis that fatty acid oxidation is reduced in response to
inactivity. In humans, non-oxidative glucose disposal, which mainly reflects glycogen
storage, was lower and glucose oxidation tended to be lower following 7 days of bed rest
in humans during a glucose clamp at a relatively low insulin infusion rate (100). After
bed rest, non-oxidative glucose disposal was also lower at high insulin infusion rates
(100). Limited data in humans also suggests that fatty acid oxidation is altered following
inactivity. After 7 days of head-down bed rest, fasting lipid oxidation was reduced by
~80% in both men and women (14). Similarly, in a study by Ritz et al. (127), fat
oxidation during fasting was significantly lower and carbohydrate oxidation higher
following long-term simulated microgravity (42 days). In addition, both fasting and
insulin-stimulated levels of lipogenesis were significantly increased in women following
7 days of bed rest (14). However, not all studies suggest altered substrate oxidation
following inactivity. Acheson et al. (1) reported that in response to 3 days of bed rest
with head-down tilt, fat oxidation during fasting was significantly increased, while
carbohydrate oxidation in response to a glucose load was unchanged. Despite this
inconsistent finding, the majority of the human studies support the hypothesis that
inactivity shifts fasting substrate metabolism toward increased reliance on carbohydrate
utilization and reduced reliance on fat oxidation and impairs insulin-stimulated glucose
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oxidation and suppression of lipolysis, all of which are characteristic features of
metabolic inflexibility.

2.6

Mechanisms underlying inactivity-induced changes to insulin action
While the mechanisms responsible for the beneficial effects of exercise are well-

studied, the cellular mechanisms involved in the rapid inactivity-related decline in insulin
action are not well-characterized. Mechanisms to explain observed decrements in insulin
action in response to inactivity may involve: changes in circulating levels of
counterregulatory hormones (144); decreased blood flow to the inactive muscles (100);
reductions in glucose transporters (GLUT-4) (138, 145); changes in the activity of
enzymes involved in glucose metabolism such as glycogen synthase (100, 109); increased
muscle glycogen concentration (44, 68, 75); and/or alterations in insulin receptor
signaling (84).
Changes in the concentrations of counterregulatory hormones influencing glucose
uptake (e.g. cortisol, growth hormone, glucagon, epinephrine) have been linked to
reduced insulin action following inactivity. Increased plasma cortisol levels were linked
to the reduction in peripheral glucose utilization in men following 30 days of bed rest
(144). Increased growth hormone concentrations after 20 days of bed rest in humans
have also been associated with decreased tissue sensitivity to insulin (144). However,
other shorter duration bed rest studies (3-14 days) report unchanged levels of
counterregulatory hormones (90, 100, 116), suggesting a possible time lag in the
counterregulatory hormone response to inactivity. Because changes to insulin action in
response to inactivity occur rapidly (119, 131) and can precede changes in
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counterregulatory hormones, there is little evidence to suggest a significant role for these
hormones in changes to insulin action (90).
Leg blood flow is reduced after 7 days of bed rest, which may decrease glucose
availability to skeletal muscle and contribute to the reduction in glucose uptake following
inactivity (100). Blood flow has been positively correlated with glucose uptake in
skeletal muscle of rats (45). However, in humans, blood flow does not appear to
independently mediate insulin-stimulated glucose uptake (110, 121). Thus, reduced
blood flow may not be a plausible mechanism to explain inactivity-related declines in
insulin action.
Lower insulin-stimulated glycogen synthase activity may contribute to reduced
insulin action in skeletal muscle in response to inactivity (109) although evidence to
support this is scarce (100). In rodents, activation of glycogen synthase by insulin was
reduced following hindlimb immobilization (109), although this observation may be
confounded by a slightly higher basal activity of the enzyme after immobilization (100).
In humans, the activity of glycogen synthase during a euglycemic-hyperinsulinemic
clamp was unaltered following 7 days of bed rest (100).
In rodents, insulin-stimulated glucose uptake is inversely related to muscle
glycogen concentration (44, 65, 75, 124). Thus, glycogen may mediate reductions in
insulin action following inactivity. However, insulin-stimulated glucose uptake was
lower following 53 hours of restricted voluntary running in rats compared to 29 hours of
restricted running despite no difference in muscle glycogen concentrations (84), which
argues against a regulatory role of muscle glycogen in the inactivity-induced decline in
insulin action (84).

16

More likely mechanisms to explain lower insulin action following inactivity are
decreased glucose transport capacity (145), changes in insulin receptors, and/or
alterations in insulin receptor signaling (84). A reversal of the adaptive increase in
GLUT-4 transporters has been associated with the decline in insulin-stimulated glucose
uptake following detraining in rodents (68, 75, 84, 124). However, Ploug et al. (119)
reported no change in GLUT-4 protein concentration in rat hindlimbs following 42-48
hours of immobilization. Conversely, in humans both short-term (145) (6 days) and
longer-term (138) (19 days) inactivity studies report significant reductions in GLUT-4
transporter levels. In a study by Vukovich et al. (145), lower insulin-mediated glucose
uptake following inactivity was directly related to lower GLUT-4 transporter protein
concentration.
Although not a consistent finding (119), results from a recent study by Kump and
Booth (84) suggest that alterations in insulin receptor binding and/or signaling mediate
the reduction in insulin-stimulated glucose uptake following reduced activity. Insulin
binding, IRβ protein concentration, insulin-mediated IRβ tyrosine phosphorylation, and
Akt Ser473 phosphorylation were reduced to sedentary values following 53 hours of
prohibited running in rats. These changes coincided with the decline in submaximal
insulin-stimulated glucose uptake, suggesting a potential mechanism for the reduction
(84). Following 42-48 hours of hindlimb immobilization, however, Ploug et al. (119)
reported no changes in insulin receptor binding or insulin receptor kinase activity. The
discrepancy in the results between these two studies may reflect differences in the
inactivity protocols, rat strains, or methodologies used to determine insulin receptor
binding or insulin signaling. Regardless, the diversity of findings suggests that the
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mechanism to explain the reduction in insulin action in response to inactivity is
multifactorial and complex.

2.7

Effect of energy imbalance on the metabolic response to inactivity
Reductions in insulin action following inactivity may also be related to energy

imbalance. Restriction of contractile activity associated with inactivity reduces overall
energy expenditure and energy demand. Thus, energy surplus (greater energy intake
relative to expenditure) and inactivity often coexist because maintaining energy balance
during extended periods of low muscle activity requires a large reduction in daily energy
intake.
Thus, the effects of inactivity on glucose metabolism may be confounded by a
greater supply of energy relative to decreased energy expenditure (i.e. energy surplus).
Energy surplus is associated with insulin resistance and may play a role in the
pathogenesis of type 2 diabetes (81). Chronic energy oversupply leads to body weight
gain over time, which contributes significant risk for developing insulin resistance and
type 2 diabetes (107). Reduced insulin action, however, appears be an early metabolic
adaptation to energy surplus (111, 115) which occurs prior to significant changes in body
weight (4, 52, 113, 146). The rapid changes to glucose metabolism as a result of energy
surplus mimic the adaptations to inactivity. Thus, energy surplus may be a key
modulator of the effects of physical inactivity on insulin action and substrate metabolism.
In obesity-prone rats, 3 days of overfeeding (an approximate doubling of caloric
intake) impaired the action of insulin to suppress hepatic glucose production, and within
7 days the rate of glucose uptake in skeletal muscle was also significantly decreased
(146). In our laboratory, we have demonstrated that a short period of energy surplus
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coupled with a reduction in structured exercise is sufficient to reduce insulin action by
~30% in healthy, active humans (52). A bout of exercise performed in a state of energy
surplus reversed the decline in insulin action, but did not return to baseline values (52).
Thus, these results suggest an independent effect of energy surplus on insulin action (52).
Therefore, it is plausible that the decline in insulin action due to inactivity may be, at
least in part, due to an excess of nutrient availability relative to the reduced metabolic
demand (energy surplus).
Although no studies to date have directly tested this hypothesis, results from a
study in young men by Dolkas and Greenleaf (32) indirectly supports the hypothesis that
energy surplus may mediate changes to insulin action in response to inactivity. The study
authors compared insulin and glucose responses to an oral glucose tolerance test between
4 conditions: a 2-wk ambulatory control (total daily energy expenditure ((TDEE)) =
~3000 kcal); 2-wk bed rest with intermittent isotonic exercise (TDEE = ~ 2940); 2-wk
bed rest with intermittent isometric exercise (TDEE = ~ 2410); and 2-wk bed rest with no
exercise (TDEE ~2160 kcal). There was a linear inverse relationship between estimated
energy expenditure and insulin area under the curve (r=0.99) (Fig. 2.2), suggesting
energy expenditure is strongly related to the insulin action response to inactivity (32).
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Figure 2.2 Regression of integrated area under insulin response curves during glucose
tolerance tests on 24-hr energy expenditures for 3 bed-rest protocols and 1 ambulatory
control. Redrawn from Dolkas et al. (32).
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Alternatively, because energy intake was constant among the 4 conditions (3073
kcal/day), differences in energy imbalance ( 



 

)

could also explain differences in the insulin response to oral glucose. In fact, a plot of
insulin area and the difference between energy intake and energy expenditures in the 4
conditions indicates a clear positive relationship between the two variables (Fig. 2.3).
The apparent relationship between insulin area in response to oral glucose and energy
surplus suggests a role for energy surplus in mediating the change in insulin action in
response to inactivity.
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Figure 2.3 Relationship between area under insulin response curves during glucose
tolerance tests and energy surplus (energy intake - energy expenditure) for 3 bed rest
protocols and 1 ambulatory control. Adapted using results from Dolkas et al. (32).
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However, data from one carefully controlled bed-rest study suggests that the
relationship between energy surplus and the change to insulin action in response to
inactivity may be more complex. Insulin-stimulated glucose uptake during a euglycemichyperinsulinemic clamp was reduced by approximately 25% following 3 days of bed rest
coupled with a high-fat diet (135). Daily energy intake was reduced by approximately
500-600 kcals (from 1.6 x RMR to 1.2 x RMR), lower insulin action cannot be explained
by energy imbalance. Conversely, when inactivity was coupled with a high-carbohydrate
diet with the same reduction in energy intake, insulin-stimulated glucose uptake was not
reduced, suggesting that dietary composition, rather than energy balance, modulates the
inactivity-related response to insulin action, although this conclusion is tenuous since the
role of energy balance was not directly tested in this study. Alternatively, because highfat feeding for 3 days without restriction of physical activity did not impair insulin action
(135), this study suggests that energy surplus may not fully explain the decline in insulin
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action following inactivity. Instead, the story may be more complex and macronutrient
composition may also play a role in the response to inactivity.

2.8

Role of dietary composition on insulin action
Some evidence suggests that macronutrient composition of the diet affects the

insulin action response to energy surplus. In particular, a nutrient oversupply of fatty
acids may exert a more potent negative effect on insulin action than an oversupply of
carbohydrate. In lean, healthy, sedentary individuals, an increased availability of
circulating fatty acids via lipid infusion (34, 40, 139) or an increase in dietary fat (92)
impairs insulin action (34, 92), ostensibly via fatty-acid induced impairment in insulin
signaling in skeletal muscle (154), although this is not a universal finding (42). In a study
directly comparing the metabolic response to a high-fat (~55-60% fat) versus highcarbohydrate diet (62-64% carbohydrate) in humans, Bachman et al. (4) observed a
significant reduction in insulin action after 3 days on the high-fat diet, whereas no
differences were observed following the high-carbohydrate diet. However, the associated
decline in insulin action in the high-fat condition is confounded by a greater energy
intake relative to the high-carbohydrate condition (~ 767 kcal/day) (4), thus it is unclear
from this study whether there is a true independent effect of increased dietary fat
composition on insulin action. However, the results of a recent carefully-controlled study
suggest there is no independent effect of an increase in dietary fat composition on insulin
action. Following 6 days of a high-fat diet (75% energy as fat), insulin action assessed
during a euglyemic-hyperinsulinemic clamp was not impaired relative to insulin action
measured 6 days following an isocaloric low-fat diet (35% energy as fat) (22). In fact,
during the last 30 minutes of the clamp, glucose disposal was greater following the high-
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fat diet compared to the low-fat diet (22). Thus, when energy intake is carefully
controlled, an increase in dietary fat composition appears to minimally affect insulin
action.
Results from studies investigating the effects of a surplus of dietary carbohydrate
on insulin action in humans are less clear. Following administration of 50% excess
energy predominantly in the form of carbohydrate, plasma insulin concentrations were
significantly higher and hepatic glucose production greater, indicative of reduced hepatic
insulin sensitivity (129). However, four days of carbohydrate feeding did not affect the
insulin or glucose response to an oral glucose load in lean or obese men and women
despite an excess mean energy intake of ~1816 kcal/d and ~2100 kcal/d, respectively
(103).
Thus, excess carbohydrate may affect insulin action differently than excess fat.
Nonetheless, short-term overfeeding without alterations in dietary composition
(proportional increases in fat, carbohydrate, and protein) has been shown to reduce
insulin action in humans (106, 113). Therefore, the available data suggests that energy
surplus exerts a clear negative effect on insulin action, irrespective of dietary
composition.

2.9

Effects of energy surplus on substrate metabolism
Energy surplus also shifts fasting substrate oxidation toward increased

carbohydrate oxidation and decreased fat oxidation. In Pima Indian men, 5 days of
overfeeding (equivalent increases in macronutrients) reduced 24-hour fat oxidation and
increased carbohydrate oxidation (86). In addition, four days of carbohydrate
overfeeding has also been show to suppress lipid oxidation and increase plasma
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triacylglycerol levels in both lean and obese subjects (103). Lower insulin-stimulated
glucose uptake following energy surplus may also translate into reduced insulinstimulated non-oxidative and oxidative disposal. However, although non-oxidative
glucose disposal was reduced in response to an oral glucose load, oxidative glucose
disposal increased following carbohydrate overfeeding (103). Similarly, a 62% increase
in energy intake for 14 days reduced non-oxidative glucose disposal, but increased
carbohydrate oxidation (106). Thus, though energy surplus reduces lipid oxidation
during fasting conditions, insulin-stimulated carbohydrate oxidation appears unaffected.
Nonetheless, increased plasma triacylglycerol levels and decreased fat oxidation are
indicative of a metabolic state associated with the development of insulin resistance
(123).

2.10 Mechanisms linking increased energy intake to decreased insulin action
A surplus of carbohydrate calories is stored as glycogen (129). Insulin action is
inversely correlated with muscle glycogen (28). Thus, increases in muscle glycogen or
changes in the activities of glycogen-dependent proteins (e.g. glycogen synthase) may be
potential mechanisms to explain the reduction in insulin action following energy surplus.
In a study by Mott et al. (106), a 62% increase in energy intake for 13 days reduced both
fasting and insulin-stimulated glycogen synthase activity in skeletal muscle (106). Nonoxidative glucose disposal was also reduced in response to supra-physiological insulin
levels, suggesting reduced insulin action. However, reduced glucose disposal was not
related to changes in glycogen synthase activity or glycogen concentration, suggesting
other mechanisms may be involved in the change to insulin action following energy
surplus. Of note, however, subjects who exhibited the greatest decreases in glycogen
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synthase activity also had the largest increases in fasting insulin concentrations following
the overfeeding protocol (106). Thus, alterations in glycogen synthase activity may
contribute to impaired glucose metabolism following energy surplus.

2.10.1 Nutrient fuel sensors involved in the regulation of energy balance and insulin
action
Increased availability of both glucose and free fatty acids may initiate a cellular
response that contributes to the reduction in insulin action. Nutrient oversupply of free
fatty acids by lipid infusion impairs insulin-stimulated glucose uptake via effects on key
components of the insulin-signaling cascade (81). Elevations in both glucose and free
fatty acids have been shown to activate PKC isoforms (50, 73, 85, 88), which may lead to
phosphorylation of serine/threonine residues on the insulin receptor and a subsequent
impairment in insulin signal transduction (81). Thus, activation of PKC isoforms within
skeletal muscle may be involved in reduced insulin-stimulated glucose uptake following
energy surplus. Additionally, increased free fatty acids as well as glucose availability
may also upregulate the hexosamine biosynthetic pathway (HBP) (58, 81). This pathway
is hypothesized to serve as an energy sensor responsive to a surplus of calories which
may modulate insulin action (111, 112, 149). Most of the glucose entering skeletal
muscle is directed towards glycogen synthesis or glycolysis. However, a small
percentage of glucose enters the HBP after conversion to fructose-6-phosphate. The
enzyme fructose-6-phosphate-amidotransferase (GFAT) catalyzes the conversion of
fructose-6-phosphate to glucosamine-6-phosphate and regulates flux through the
pathway. The final step in HBP is the formation of uridine diphosphate Nacetylglucosamine (UDP-GlcNAc), a main substrate for protein glycosylation (111, 149).
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Early observations that inhibition of GFAT could prevent hyperglycemia-induced insulin
resistance suggested a role for the HBP as an energy sensor modulating insulin action
(111, 149). Further, UDP-GlcNAc levels are also responsive to changes in nutrient
intake.

In rats, UDP-GlcNAc levels were 68% higher following overfeeding compared

to controls (146). Conversely, calorie restriction reduces UDP-GlcNAc levels, further
implicating its role as an energy sensor (46). Although HBP is most sensitive to changes
in glucose, increased dietary fat availability also leads to increased flux through HBP and
UDP-GlcNAc in skeletal muscle (58).
HBP activation via glucosamine administration increases UDP-GlcNAc
concentrations and reduces insulin-stimulated glucose uptake (115, 149). Overexpression
of GFAT in skeletal muscle and adipose tissue in mice also induces insulin resistance
(63), further suggesting a link between HBP and insulin action (111). It is postulated that
key proteins of the insulin-signaling pathway may undergo posttranslational modification
via glycosylation with UDP-GlcNAc, potentially explaining a mechanism by which HBP
activation reduces insulin-stimulated glucose uptake (111, 115). Activation of HBP has
been shown to downregulate genes involved in oxidative phosphorylation and fatty acid
oxidation in rat skeletal muscle (112), which may indirectly reduce insulin action.
Malonyl-CoA levels may also serve as a fuel sensor that may regulate substrate
oxidation in response to energy surplus (111). Malonyl-CoA is an intermediate in fatty
acid synthesis and inhibits carnitine palmitoyl transferase-1 (CPT1), which controls
transport of free fatty acids into the mitochondria for oxidation. High concentrations of
both glucose and insulin increases malonyl-CoA levels and suppresses lipid oxidation
(111, 122). Decreased capacity to oxidize free fatty acids may increase the intracellular
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pool of fatty acid moieties, which may impair insulin action via fatty acid inhibition of
insulin signal transduction discussed above (81). In summary, increased energy intake
may induce multiple and complex mechanisms involved in the regulation of energy
balance and insulin action (111).

2.11 Summary
Data from hindlimb suspension studies in rodents and bed rest studies in humans
indicate that inactivity exerts clear deleterious effects on insulin action and lipid
metabolism. However, no published studies have examined the metabolic impact of a
more relevant mode of inactivity, i.e. prolonged sitting in humans. Energy surplus causes
similar impairments to insulin action and lipid metabolism. Thus, the effects attributed to
inactivity may be confounded by a concurrent energy surplus. However, to our
knowledge, no studies have investigated the combined effect of a high calorie diet and
inactivity on insulin action. Therefore, the aims of this study were to evaluate the effects
of short-term inactivity (sitting) with or without energy surplus on insulin action.
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CHAPTER 3
METHODOLOGY

3.1

Overall design
An overview of the study design is shown in Figure 3.1. A cross-over design was

used in which each subject completed 3 experimental conditions. Each condition required
a 24-hour laboratory stay and the order of the conditions was counter-balanced across
subjects. In 2 conditions, subjects remained seated for ~16 of the 24 hours to restrict
physical activity (INACTIV and INACTIV LO-CAL). The 3rd condition served as an
active condition in which subjects stood and performed activities of daily living for
approximately 12 of the 24 hours (ACTIV). All meals (i.e. breakfast, lunch, and dinner)
were provided throughout the 24-hour period. For ACTIV, energy intake approximated
energy expenditure (i.e. energy balance). Energy intake in INACTIV was identical to that
in ACTIV (energy intake > energy expenditure, i.e. energy surplus). In INACTIV LOCAL, energy intake was reduced to more closely match the lower energy expenditure (i.e.
energy balance) (Table 3.1). Insulin action was measured in the morning approximately
12 hours following the evening meal in each condition.

Figure 3.1 Overview of study design
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Table 3.1 Average energy intake and expenditure across conditions (M ± SD).
Energy Balance
Energy Intake

Energy Expenditure

(kcals/day)

(kcals/day)

(EI-EE)
(kcals/day)
ACTIV

3106 ± 590a

2944 ± 462

162 ± 248a

INACTIV

3133 ± 583a

2195 ± 424b

938 ± 202a

INACTIV LO-CAL

2109 ± 428

2139 ± 427b

-30 ± 82

a
b

Significantly different from INACTIV LO-CAL
Significantly different from ACTIV

3.2

Subjects
Fourteen men (n=7) and women (n=7) between the ages of 20 and 32 years (26.1

± 4.5) were recruited from the surrounding area by flyers and advertisements to
participate in this study. Each subject completed all 3 trials except for one male and one
female who only completed 2 out of 3 trials due to an adverse event and time constraints,
respectively (ACTIV and INACTIV; and ACTIV and INACTIV LO-CAL, respectively).
Subject characteristics are presented in Table 3.2. All volunteers were in good health, of
normal body composition (23.7% body fat), and aerobically fit (VO2peak = 49.1 mg•kg1

•min-1). All subjects were recreationally active, meeting the physical activity guidelines

(i.e. at least 30 minutes of moderate exercise, 3 days a week or more) as determined by a
generic physical activity questionnaire. All subjects were non-smoking, free of known
disease (e.g. cardiovascular disease, type 2 diabetes, etc.), not following a very low or
very high-carbohydrate diet (<30% or >70% carbohydrate, respectively), and were not
taking any medications (e.g. metformin, insulin, statin drugs) or supplements (e.g.
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chromium, vanadium, ephedra) known or suspected to alter carbohydrate or lipid
metabolism. Four females were taking monophasic birth control. The study protocol was
approved by the Institutional Review Board at the University of Massachusetts, Amherst
prior to initiation of the study and all subjects gave their verbal and written informed
consent before participating.

Table 3.2 Subject characteristics (n=14; 7M, 7F)
Average (M ± SD)

Range

Age (years)

26.1 ± 4.5

19.8 – 32.2

Weight (kg)

69.5 ± 13.2

49.6 – 89.7

Height (cm)

170.9 ± 10.1

152.0 – 188.

BMI

23.6 ± 3.0

18.8 – 29.2

% Fat

23.7 ± 7.1

13.0 – 36.6

Lean mass (kg)

53.4 ± 13.4

35.6 – 78.0

VO2peak (mg•kg-1•min-1)

49.1 ± 3.3

40.5 – 52.4

Physical activity (hrs/week)

2.8 ± 1.2

1.5 – 8.0

3.3

Preliminary testing
Prior to participating in the experimental protocol, body composition (fat mass,

fat-free mass, and % body fat) was assessed by dual energy x-ray absorptiometry
(DEXA) (Lunar, Madison, WI). Subjects completed a graded, continuous exercise test
on a treadmill (LifeFitness 9100 HR, Schiller Park, IL) to assess peak oxygen
consumption (VO2peak). The test commenced at a low work rate (e.g. 5.0 miles per hour)

30

with incremental increases in treadmill grade (e.g. +2% every 2 minutes) and/or speed
(e.g. +0.5 miles per hour) until a peak voluntary effort was achieved. Gas exchange
measurements were obtained continuously throughout the test by open-circuit spirometry
(TrueMax2400 Metabolic Measurement System, Parvomedics, Salt Lake City, UT).
Heart rate was measured and recorded throughout the test by telemetry using a Polar
monitor (Polar Electro Oy, Kempele, Finland). Peak effort was defined as achievement
of at least two of the following criteria: 1) RER ≥ 1.10; 2) peak heart rate ≥ 95% of agepredicted maximum (220-age) and 3) a plateau in VO2 as defined by an increase of < 150
ml·kg·min-1 between the penultimate and final stage of the test. All of the subjects
achieved at least two of these three criteria and all tests were considered a valid
assessment of peak oxygen consumption.
Daily physical activity was assessed 2-4 days prior to each trial using an activPal
professional physical activity monitor (PAL Technologies Ltd, Glasgow, Scotland). The
activPal physical activity monitor is a single unit monitor based on a uni-axial
accelerometer that is worn midline on the anterior aspect of the thigh. It produces a
signal related to thigh inclination and can sense periods of walking, sitting and standing
and is thus useful for measuring both activity and inactivity. The monitor also records
step count and cadence. A software package (activPAL Professional Research Edition)
summarizes activity over 1 hour periods in graphical and numeric formats based on
proprietary algorithms. The activPAL has been shown to be a valid and reliable
measurement tool for determining posture and motion during activities of daily living in a
healthy population (48). Subjects were instructed to wear the monitor on the midline of
the right thigh. These data were used to objectively quantify each subject’s habitual
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activity levels and energy expenditure during typical exercise and non-exercise days.
The data were also used to determine any potential impact of prior physical activity and
energy expenditure on outcome measures during the study. The activPal was also worn
during all 24-hour laboratory visits. These data was used to quantify 24-hour energy
expenditure during the 3 conditions (i.e. 8 A.M. – 8 A.M.).

3.3.1

Estimated energy expenditure and energy intake
To estimate total daily energy expenditure (TDEE) and energy intake in this

sample, we have previously used the protocol described below (12, 52). Resting energy
expenditure (REE) was measured in the morning after an overnight fast. Upon arrival,
subjects lay supine in a quiet room for 30 minutes. A ventilated hood was placed over
the subject’s head and respiratory gases were collected using indirect calorimetry
(TrueMax2400 Metabolic Measurement System, Parvomedics, Salt Lake City, UT) for
30 minutes. To estimate energy requirements for the day prior to each 24-hour laboratory
visit, the REE was multiplied by an activity factor varying between 1.5-1.7 based on
habitual physical activity as determined by questionnaire. Energy requirements estimated
from REE using the appropriate activity factor are strongly correlated (r= 0.73) with
energy requirements measured during 28 days of controlled feeding (78). Energy
requirements during ACTIV and INACTIV were calculated by multiplying REE by 2.05
and requirements during INACTIV LO-CAL were calculated using a factor of 1.39 *
REE based on estimates provided by Hamilton and colleagues (personal communication)
using study designs similar to ours. Subjects were provided with all meals the day prior
to, and the day of, each 24-hour laboratory visit in order to control energy intake. Meals
consisted of commercially prepared frozen entrees and foods prepared and weighed in the
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Energy Metabolism Laboratory (e.g. cereal, bagel, fruit, peanut butter, etc.). Subjects
were asked to consume all food provided as discrete meals at certain times of the day
(breakfast, lunch, dinner, etc.). Subjects were instructed to refrain from alcohol and
caffeine for 24 hours prior to each 24-hour laboratory visit. Average daily macronutrient
composition on the day prior to the 24-hour intervention was 55% carbohydrate, 29% fat,
and 16% protein; average daily macronutrient composition during the 24-hour
intervention was 54% carbohydrate, 29% fat, and 16% protein.

3.3.2

Control for menstrual cycle phase
Although the data are not consistent, some studies show that insulin sensitivity is

lower in the luteal phase of the cycle compared with the follicular or menstrual phase (31,
142, 153). As previously mentioned, 4 females were taking monophasic birth control so
all testing was conducted in a single cycle phase in these women. Based on self-reported
onset and cessation of menses, one female completed all experimental conditions in the
luteal phase; one completed 2 conditions in the luteal and the 3rd condition (ACTIV) in
the follicular phase. For one woman with a history of irregular menstrual cycles, it was
impossible to determine menstrual cycle phase during any experimental condition.
However, because all but 2 female subjects completed all experimental conditions in a
single cycle phase, results of this study were likely unaffected by variations in menstrual
cyclicity.

3.4

Experimental protocol
Subjects completed three, 24-hour visits to the laboratory in a counter-balanced

order with at least a week between visits. Three days prior to arrival in the laboratory
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(Day -3), subjects were asked to perform 30 minutes of moderate exercise (e.g. jogging,
cycling, etc.) at approximately 8 P.M. Subjects were instructed to perform the same
exercise bout (i.e. same mode, duration, and intensity) before each visit. For the 2 days
prior to each 24-hour intervention, subjects were instructed to refrain from any structured
exercise (i.e. no physical activity beyond activities of daily living). All meals were
provided the day prior to each 24-hour visit (Day -1) and were standardized across
conditions. Average energy intake on Day -1 was 2321 ± 506 kcal/day. Daily
macronutrient composition was 55% carbohydrate, 29% fat, and 16% protein. On the
morning of Day 1, approximately 12 hours after the evening meal, subjects reported to
the Energy Metabolism Laboratory for the 24-hour visit. Upon arrival, subjects were
seated and a butterfly needle was inserted into a forearm vein and 5 ml of blood was
drawn for the measurement of fasting plasma triacylglycerol concentration. Subjects
were then given a standardized breakfast to eat and were shown to their designated room
equipped with a chair, desk, and futon. Subjects were provided access to a computer with
internet service, books and magazines, or movies throughout the day and evening. A
standardized lunch and dinner were given at approximately 12 P.M. and 5 P.M.,
respectively. After an overnight stay in the laboratory, insulin action was assessed in the
morning (Day 2) approximately 10-12 hours following the evening meal.
During ACTIV, total sitting time throughout the day was restricted and subjects
sat for approximately 32% of total waking hours (Table 3.3), which is less than the
amount of sedentary time in a typical individual (i.e. 55% of the waking day) (97).
Subjects stood while reading, talking on the phone, or working on the computer, walked
at a low to moderate intensity (≤ 3 mph) or performed activities of daily living (e.g.
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sweeping, bending to pick up books, vacuuming, etc.). All subjects were instructed to
perform standardized tasks and activities at specific times during the day based on an
activity “menu”. The energy expenditure goal for 24 hours was 2.05 * REE. To create
the menu, low-intensity activities (≤ 3.8 METs) were chosen from a list of select
household activities (e.g. sweeping, dusting, vacuuming, dish washing, etc.) with directly
measured MET values from a study of 102 individuals (Freedson et al. unpublished data).
Three additional activities with estimated MET values were selected from the Physical
Activity Compendium (i.e. dart throwing, take out trash, put away groceries) (2). A
sample schedule of activities is provided in Appendix A. During INACTIV and
INACTIV LO-CAL, walking and standing was restricted and subjects spent
approximately 98% of the waking day sitting (Table 3.3), which is much greater than the
amount of time spent in sedentary behaviors in a large population sample in the United
States (i.e. 55%) (97). A wheelchair was provided to transport the subjects within the
laboratory and building. Energy expenditure during these two conditions was
approximately the same (2195 ± 424 and 2139 ± 427 for INACTIV and INACTIV LOCAL, respectively) and was significantly less than energy expenditure during ACTIV
(2944 ± 462).
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Table 3.3 Total sitting, standing, stepping, and sleep time during the 3, 24-hour conditions (M±SD).

Sitting Time

Standing Time

Stepping Time

Sleep Time

Total steps

(hrs)

(hrs)

(hrs)

(hrs)

(steps/day)

5.8 ± 1.7

9.8 ± 0.5

2.2 ± 0.4

6.1 ± 1.3

9913 ± 1669

INACTIV

16.9 ± 1.0a

0.2 ± 0.2a

0.1 ± 0.1a

6.8 ± 1.1a

264 ± 0.4a

INACTIV LO-CAL

16.8 ± 1.5a

0.3 ± 0.1a

0.1 ± 0.0a

6.8 ± 0.6a

251 ± 195a

ACTIV

a

Significantly different from ACTIV.
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3.4.1

Standardized meals
The energy content and composition of the evening meal (3 personal cheese

pizzas and a Swiss cheese wedge) was identical both between subjects and across all
conditions (1030 kcals, 39% fat, 18% protein, 43% carbohydrate) in order to standardize
the effect of the previous meal on insulin action. The meal was also identical in content
and composition to the meal consumed on the evening of Day -1 to allow for the
comparison of fasting triacylglycerol concentrations from Day 1 to Day 2 without the
potential confounding effect of the prior meal. The carbohydrate composition of breakfast
and lunch was increased so that average daily macronutrient composition on Day 1 was
54% carbohydrate, 29% fat, and 16% protein. Breakfast and lunch consisted of solid
foods (e.g. cereal, bread, deli meats), juice, or non-caffeinated soft-drink beverages. For
all conditions, dietary composition, the timing of meals, and the time interval between the
evening meal and the measurement of insulin action was held constant. However, the
energy content of breakfast and lunch on Day 1 was lower in INACTIV LO-CAL
compared to INACTIV and ACTIV. Total daily energy intake was the same in ACTIV
and INACTIV (3106 ± 590 and 3133 ± 583, respectively), but energy intake in INACTIV
LO-CAL was reduced to approximate the reduction in energy expenditure (2109 ± 428).
Subjects were allotted 25 minutes to eat each meal.

3.5

Assessment of insulin action and other metabolic variables
Ten to 12 hours after the evening meal, insulin action was assessed using a 1-hour

continuous infusion of 20% glucose that contained a 2% stable [6,6-2H] glucose isotope
tracer (Cambridge Laboratories, Andover, MA), as previously described (12, 134).
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Indwelling catheters were placed in a superficial vein of each forearm for venous blood
sampling and continuous infusion of the isotope tracer. Venous blood samples were
collected to determine naturally occurring levels of isotopic enrichment prior to the
infusion. These samples were also used to compare changes in fasting triacylglycerol
levels from Day 1 to Day 2. A priming bolus of 200mg [6,6-2H] glucose was given
followed by a 90-minute infusion of 2.0% [6,6-2H] glucose isotope at a rate of 3.0mg/min
delivered by a peristaltic infusion pump (Harvard Apparatus Pump 22, Holliston, MA).
Respiratory gases and venous blood samples were collected at 0, 75 and 90 min. At 90min, the infusate was changed to 20% dextrose containing 2.0% [6,6-2H] glucose
delivered at a rate of 8.45mg/kg FFM/min for 60 min. Blood samples and respiratory
gases were collected at 50, 55, and 60 minutes of the glucose/stable isotope infusion to
determine glucose rate of appearance (Ra) and disappearance (Rd) as well as plasma
concentrations of glucose and insulin. Glucose and insulin concentrations from minutes
50, 55, and 60 were averaged to determine the steady-state glucose (SSPG) and insulin
(SSPI) concentrations. Insulin action was determined using the isotopically-determined
glucose uptake scaled to steady-state insulin concentrations during the continuous
infusion. This procedure for the assessment of insulin action was identical among the
three different treatment conditions.

3.6

Blood collection and biochemical analysis
Venous blood was collected in vacutainers containing a glycolytic inhibitor

(sodium fluoride) and potassium oxalate for analysis of glucose and glucose isotopic
enrichment. In addition, vacutainers containing EDTA were used for the analysis of
insulin, triacylglycerols, and free fatty acids. After collection, samples were immediately
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centrifuged at 3300 rpm with a maximum force of 1380 x G for 10 minutes. Plasma
aliquots were stored in 2ml cryotubes at -80° C until analysis.
Plasma glucose concentrations were determined by the glucose oxidase method
using a GL5 Analox Analyzer (Analox Instruments, Lunenberg, MA). Insulin
concentrations were determined using a radioimmunoassay kit specific for human insulin
(Linco Research Inc. St. Charles, MO). Free fatty acid and triacylglycerol concentrations
were determined with an enzymatic colorimetric assay kit (Wako Chemicals USA Inc.,
Richmond, VA, and Sigma Chemical, St. Louis, MO, respectively).

3.7

Plasma isotopic enrichment
Glucose isotopic enrichment was determined using liquid chromatography-mass

spectrometry (LCMS) according to the methods outlined by McIntosh et al. (99). Serum
samples (0.3 mL) were placed in 1.7-mL microcentrifuge tubes containing 1 mL of icecold acetone. Samples were vortexed and incubated for 10 minutes at -20◦C; after
chilling, samples were centrifuged for 2 min at 17,000g at 4◦C. The supernatant was
transferred to 12 X 75-mm borosilicate tubes (Fisher Scientific Inc., Pittsburgh, PA) and
concentrated to dryness under ambient conditions. Once dry, samples were reconstituted
with 0.3 mL 75:25 acetonitrile to water, vortexed, and transferred through a
polyethersulfone filter (4 mm, 0.45 µm) into a glass HPLC vial and capped (Fisher
Scientific Inc., Pittsburgh, PA). Vials were loaded into the autosampler compartment of
the LC (Agilent 1100 series, Agilent Technologies, Santa Clara, CA) and set to an
injection volume of 10 µL. The LC conditions were as follows: isocratic mobile phase
75:25 acetonitrile to water; flow rate of 1.0 mL•min-1; column temperature 35◦C.
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Glucose eluted from the column at approximately 6 min, therefore, total run time on the
column was set to 10 min. After the compounds were separated using a Shodex
Asahipak NH2P-50, 4.6 x 250 mm column (Showa Denko America, Inc., New York,
NY), they were ionized by electrospray in the MS (Esquire 6000 (Bruker Daltronics Inc.,
Billerica, MA) and detected under the following conditions: capillary, 5500 V; endplate
offset, 500 V; nebulizer 30.0 psi; dry gas 10.0 L•min-1; dry temperature, 300◦C; scan
range 100-210 m/z.
For chromatogram analysis (Bruker Data Analysis software, Bruker Daltronics,
Inc.), the glucose peaks were isolated, integrated, and the average mass-to-charge ratio
was generated. Isotopic enrichment of the [6,6-2H] glucose (m/z = 205) was expressed as
a percentage of the total glucose species (m/z = 203 + 204 + 205) as follows:
% isotopic enrichment =

3.8
3.8.1

203

* 100

203+204+205

Calculations
Isotope-derived glucose turnover
Glucose rate of appearance (Ra) =

 //


Glucose rate of disappearance (Rd) = $

%

 !" #

!






F represents the isotopic infusion rate. IE1 and IE2 are the isotopic enrichments
(ratio of labeled [6,6-2H] glucose to total plasma glucose) at time-points t1 and t2,
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respectively. C1 and C2 are the concentrations of plasma glucose at t1 and t2, and V is the
estimated volume of distribution for glucose of 180 ml/kg.
Whole body insulin action was defined as glucose Rd/SSPI, where SSPI is the
mean plasma insulin concentration during the final stages of the infusion (12, 130).
Hepatic insulin action was defined as the percent suppression of basal hepatic
glucose production (HGP) during the glucose infusion, where greater suppression
indicates greater hepatic insulin action =

1

'()*+,-.*/+
'(),0.*+1

2 100.

HGPfasting is equal to the basal rate of appearance while HGPinfusion during the infusion is
calculated as: 5  5  6785 $

3.8.2

6785 958  .

Oxidative and non-oxidative glucose disposal
Glucose oxidative disposal was assumed to equal the carbohydrate oxidation rate

during the continuous infusion of glucose. Non-oxidative glucose disposal, usually
attributed to glucose storage, was expressed as a percentage of total glucose Rd and
calculated as:
(:-;/.< =>/0: ;0?@/AB>?0< /C*>0*/+ ?0<
(:-;/.< =>

3.8.3

2 100.

Metabolic flexibility
Whole-body substrate oxidation was estimated by calculating the respiratory

exchange ratio (RER) in the fasted conditions and during the final 10 minutes of the
glucose infusion using indirect calorimetry. Low RER values (i.e. 0.70-0.85) reflect a
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greater reliance on fat oxidation where high RER values reflect greater reliance on
carbohydrate oxidation (0.85-1.00). In subjects with “normal” insulin action, the elevated
insulin concentrations during the infusion of glucose cause an abrupt increase in RER,
indicative of a “switch” from primarily fat oxidation in the fasted state to primarily
carbohydrate oxidation during the glucose infusion. The magnitude of the switch (∆
RER) was used as an index of metabolic flexibility.

3.8.4

Substrate oxidation
Fasting and insulin-stimulated carbohydrate and fat oxidation rates were

calculated from the VO2 and VCO2 using the formulas of Péronnet and Massicotte (117):
Fat oxidation rate (g/min) = 1.6946 %G2 – 1.7012 %KG2
Carbohydrate oxidation rate (g/min) = 4.5850 %KG2 – 3.2255 %G2

3.9

Power and sample size analysis
The sample size required to test for significant differences in insulin action

between group means was calculated based on mean differences and intra-individual
variances from a study on the acute effects of energy surplus in a similar subject
population (52). Since the most pertinent comparisons for this study were between
INACTIV and INACTIV LO-CAL, the power calculations were based on a paired twosample t-test (alpha level 0.05) of the two-sided null hypothesis that the difference
between these two group means was zero. Based on this calculation, testing 13 subjects
would provide 80% power to detect a 20% difference in insulin action between these two
conditions. A 14th subject was included for gender balance (i.e. 7 men, 7 women).

42

3.10 Statistical analysis
Differences in insulin action, glucose kinetics, substrate oxidation, and substrate
and hormone variables between the three conditions were analyzed by means of linear
mixed-effects models with planned contrast analyses using the R statistical software
package, version 2.2.1 (R: A language and environment for statistical computing, R
Foundation for Statistical Computing, Vienna, Austria, 2005, http://www.R-project.org).
In addition, to determine which factor (inactivity vs. energy surplus) had a greater effect
on insulin action we fit a model to test the separate effects of condition (inactive and
active) and energy status (balance and surplus). All non-normally distributed data were
log-transformed prior to analysis. Statistical significance was accepted at p < 0.05.
Subject characteristics are presented as mean ± standard deviation; all other data are
expressed as mean ± standard error of the mean.
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CHAPTER 4
RESULTS

4.1

Plasma glucose and insulin
Fasting plasma glucose concentrations were not significantly different among any

of the 3 conditions (ACTIV = 4.91 ± 0.02 mmol•L-1, INACTIV = 5.04 ± 0.03 mmol•L-1,
INACTIV LO-CAL = 4.91 ± 0.02 mmol•L-1). Similarly, steady-state plasma glucose
(SSPG) during the glucose infusion (ACTIV = 9.3 ± 0.1 mmol•L-1, INACTIV = 9.4 ± 0.1
mmol•L-1, INACTIV LO-CAL = 9.2 ± 0.1 mmol•L-1) were also not different among the 3
conditions. Fasting insulin concentrations were greater in both INACTIV and INACTIV
LO-CAL (47.6 ± 1.4 pmol•L-1 and 43.7 ± 1.9 pmol•L-1, respectively) compared with
ACTIV (39.9 ± 0.9 pmol•L-1) although these differences were not statistically significant.
Fasting insulin concentrations also were not different between INACTIV and INACTIV
LO-CAL. Compared to control (ACTIV), steady-state plasma insulin (SSPI)
concentrations were 41% higher in INACTIV (p < 0.001) and 20% higher in INACTIVLO CAL (p=0.08) (Figure 4.1). Insulin concentrations during the glucose infusion were
also 18% greater in INACTIV compared to INACTIV LO-CAL (p = 0.02) (Figure 4.1).
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Figure 4.1 Steady-state plasma insulin (SSPI) concentrations during the continuous
infusion of glucose across the 3 conditions. * p < 0.05.

*

*
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4.2

Glucose turnover
Whole-body glucose rate of disappearance (Rd) and hepatic glucose production (HGP) before (fasting) and during the glucose

infusion are shown in Table 4.1. During the infusion, total glucose Rd was significantly lower in INACTIV compared to both
ACTIV (p < 0.001) and INACTIV LO-CAL (p = 0.05). Total glucose Rd was also lower in INACTIV LO-CAL compared to ACTIV
although this difference was not significant (p = 0.08).

Table 4.1 Comparison of glucose turnover across the 3 conditions.
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Glucose Rd fasting

Glucose Rd infusion

HGPfasting

HGPinfusion

ACTIV

21.5 ± 0.3

51.1 ± 0.6

24.0 ± 0.5

9.1 ± 0.6

INACTIV

21.7 ± 0.8

47.4 ± 0.8a

22.4 ± 0.8

6.3 ± 0.5

INACTIV LO-CAL

20.6 ± 0.5

48.7 ± 1.0a

21.7 ± 0.5

7.1 ± 1.0

Note: Glucose Rd, glucose rate of disappearance; HGP, hepatic glucose production.
Units for all variables are umol•L-1•min-1•kgFFM-1
Data are mean and standard error.
a
Significantly different from ACTIV

4.3

Insulin action

Insulin action, as defined by Rd/SSPI, was reduced relative to ACTIV by 39% in
INACTIV (p < 0.001) and by 18% in INACTIV LO-CAL (p = 0.07) (Fig.4.2). Rd/SSPI
was also higher in INACTIV LO-CAL compared to INACTIV (p = 0.04).
Because insulin action was lower in both INACTIV and INACTIV LO-CAL
compared to ACTIV, we further examined which factor (energy status, i.e. balance vs.
surplus, or inactivity) was the strongest contributor to insulin action. To do this, we fit a
model using energy status and activity status (i.e. inactivity vs. activity) as factors.
According to the model, only the effect of energy status was significant (p < 0.05),
indicating that energy status has a more potent effect on insulin action compared to
activity status.
To determine whether sex (male/female) or energy balance on Day -1 influenced
the insulin action response, we performed a separate analysis incorporating these factors
(i.e. sex, energy balance on Day -1) into the model. Unexpectedly, there was a significant
effect of sex on insulin action, such that insulin action was higher in women compared to
men. However, there was no sex by condition interaction suggesting the response to the
intervention was the same regardless of sex. There was no significant effect of energy
balance on Day -1 on insulin action (p > 0.05). Therefore, differences in insulin action
between conditions cannot be explained by energy balance on Day -1.
The energy content and composition of the evening meal on Day 1 was the same
for each subject across all 3 conditions (i.e. 1030 kcal). Therefore, the percent
contribution of the evening meal to total daily energy intake (% contribution) varied
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between subjects (i.e. higher % contribution in subjects with low total daily energy intake
and vice versa) and between condition (i.e. higher % contribution in INACTIV LO-CAL
compared to ACTIV and INACTIV). To assess whether % contribution of the evening
meal had a significant impact on insulin action, we included % contribution of the
evening meal into the model formula. There was no significant effect of % contribution
of the evening meal on Rd/SSPI, nor did its inclusion in the model affect model outcomes.
Figure 4.2 Insulin action (Rd/SSPI) assessed during the continuous infusion of glucose
across the 3 conditions. SSPI, steady-state mean of 50, 55, and 60 min plasma insulin
concentrations. * p < 0.05.

*

*

4.4

Partitioning of insulin-mediated glucose disposal
Non-oxidative glucose disposal, expressed as a percentage of total glucose Rd,

was higher and percent oxidative disposal was lower in INACTIV LO-CAL compared to
INACTIV (p < 0.05) (Figure 4.3). Non-oxidative glucose disposal was greater (61± 2.0%
vs. 54 ± 1.3%) and oxidative disposal was lower (39 ± 2.0% vs. 46% ± 1.3) in INACTIV
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LO-CAL compared to ACTIV, respectively, although these differences were not
significant (p > 0.05). There were no differences in non-oxidative or oxidative glucose
disposal between ACTIV and INACTIV (p > 0.05).
Figure 4.3 Partitioning of insulin-mediated glucose disposal (Rdinfusion) across the 3
conditions. The open (white) portion of the column reflects non-oxidative disposal and
the gray portion reflects CHO oxidation. *, p < 0.05 when compared with INACTIV.

*

*

Basal glucose Ra (HGPfasting) and hepatic glucose production during the infusion
(HGPinfusion) were similar between the 3 conditions (Table 4.1). In all 3 conditions, the
glucose infusion partially suppressed HGP, with residual HGP lowered to 27-38% of
fasting values. Hepatic insulin action, defined as percent suppression of HGPfasting during
the infusion, was not significantly different between the 3 conditions (Figure 4.4).
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Figure 4.4 Hepatic insulin action (percent suppression of fasting hepatic glucose
production during the glucose infusion) across the 3 conditions.

4.5

Markers of lipid metabolism
Fasting triacylglycerol (TAG) concentrations on Day 1 were similar across the 3

conditions (p > 0.05) (Figure 4.5). Fasting TAG concentrations on Day 2 (i.e. prior to the
continuous infusion of glucose) were 27% lower in the active condition (ACTIV)
compared to INACTIV (p < 0.01) (Figure 4.5). TAG levels were also 20% lower in
INACTIV LO-CAL compared to ACTIV, although this difference was not significant (p
> 0.05). There were no differences in fasting TAG concentrations on Day 2 between
INACTIV and INACTIV LO-CAL (p > 0.05). To further examine whether there was an
effect of intervention on fasting TAG concentrations, we examined the change in fasting
TAG from Day1 to Day 2 (i.e. ∆ TAGfasting (Day 2 – Day 1) (Figure 4.6). The change to
fasting TAG levels were much smaller in INACTIV (+3%, p < 0.01) and INACTIV LOCAL (-6%, p = 0.10) compared to ACTIV (-20%) (Figure 4.6). During the continuous
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infusion of glucose, TAG concentrations were not different between conditions (p > 0.05)
(Table 4.5).
Fasting and insulin-stimulated plasma free fatty acid (FFA) concentrations were
similar among the 3 conditions. There were also no differences in fasting or insulinstimulated lipid oxidation (LIPIDox (mg•min-1)) between conditions, although LIPIDox
during the glucose infusion was slightly greater in INACTIV LO-CAL compared to
INACTIV (p = 0.08) (Table 4.2). Similarly, respiratory exchange ratios (RER) were
similar across conditions in the fasted state (Figure 4.7). However, during the glucose
infusion, RER values were significantly higher in ACTIV (p = 0.05) and INACTIV (p =
0.02), indicating greater reliance on carbohydrate oxidation compared to INACTIV LOCAL (Figure 4.7).
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Table 4.2 Markers of lipid metabolism across the 3 conditions.
LIPIDoxfasting LIPIDoxinfusion
(mg•min

-1

)

(mg•min-1)

∆ LIPIDox

FFAfasting

FFAinfusion

∆FFA

TAGfasting

TAGinfusion

%

(mmol•L-1)

(mmol•L-1)

%

(mg•dL-1)

(mg•dL-1)

ACTIV

95.6 ± 3.1

60.8 ± 2.9

-39.9 ± 2.3

0.27 ± 0.01

0.08 ± 0.00

-68.4 ± 1.2

62.3 ± 2.2

62.8 ± 2.3

INACTIV

86.4 ± 3.3

57.8 ± 2.4

-33.7 ± 2.5

0.24 ± 0.01

0.07 ± 0.00

-68.6 ± 1.3

79.2 ± 2.9a

72.3 ± 2.9

98.9 ± 2.9

71.0 ± 2.9

-31.2 ± 2.2

0.31 ± 0.01

0.08 ± 0.00

-73.9 ± 1.1

74.8 ± 4.3

68.8 ± 3.3

INACTIV
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LO-CAL
Note: ∆, % Change (Infusion – Fasting); LIPIDox, rate of lipid oxidation; FFA, free fatty acid; TAG, triacylglycerol. Data are mean
and standard error.
a

, Significantly different from ACTIV

Figure 4.5 Fasting TAG concentrations on Day 1 (in gray) and Day 2 (in black) across
the 3 conditions. * p < 0.05 when compared with ACTIV.

*

Figure 4.6 Change in fasting TAG concentrations from Day 1 to Day 2 across the 3
conditions.* p < 0.05 when compared with ACTIV.

*
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To examine whether there were differences in the suppression of FFAs and
LIPIDox by the elevated circulating insulin concentrations during the infusion, we
compared the change in FFA from the fasted to insulin-stimulated state (∆FFA) as well as
the percent change in lipid oxidation rates (∆LIPIDox) in all 3 conditions (Table 4.2).
There were no significant differences in either variable (∆FFA and ∆LIPIDox) between
conditions. We also compared the change in the respiratory exchange ratio from the
fasted to insulin-stimulated state (∆RER) to examine differences in metabolic flexibility
between conditions. Although there was a more dynamic increase in RER, as indicated
by a steeper slope of the line in Figure 4.7., in ACTIV compared to INACTIV and
INACTIV LO-CAL, there were no significant differences in ∆RER between conditions.
Figure 4.7 Respiratory exchange ratio (RER) across the 3 conditions. *, p ≤ 0.05 when
compared with INACTIV LO-CAL.

*
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CHAPTER 5
DISCUSSION

The purpose of this study was to determine the metabolic response to one day of
inactivity (prolonged sitting), with and without the potential confounding effect of energy
surplus, in healthy, young adults. To test the specific aims, we compared the metabolic
response to 24 hours of: 1) high non-exercise activity with energy intake = energy
expenditure (ACTIV); 2) inactivity (sitting) with energy intake > expenditure, i.e. energy
surplus (INACTIV); and 3) inactivity with energy intake = expenditure (INACTIV LOCAL). The main findings of the study were: 1) compared to the active condition, 24hours of inactivity, with no change to diet, significantly reduced insulin action; and 2)
reducing energy intake to match low energy expenditure during inactivity (INACTIV
LO-CAL) significantly attenuates, but does not completely prevent, the deleterious effect
of inactivity on insulin action. Thus, mechanisms other than energy surplus are also
involved in the inactivity-induced decline in insulin action.
Several studies in animals and humans have reported clear, deleterious
consequences of inactivity on metabolic processes including insulin action (8, 14, 90,
100, 114, 119, 131, 137). The time course of metabolic changes is not clear from these
studies due to different inactivity protocol durations. For example, studies in rodents
report significant declines in insulin-stimulated glucose uptake in as little as 24-48 hours
following hindlimb immobilization (119, 131). In humans, the earliest detectable
reduction in insulin action has been observed following 3 days of bed rest (90, 133).
Notably, the present study is the first to document considerable reductions in whole-body
insulin action following just one day of inactivity in humans. Further, the magnitude of
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the reduction in insulin action in such a short period of time is remarkable considering the
similar declines (~30%) reported after longer periods (i.e. days - weeks) of inactivity (90,
100, 133). Therefore, reduced insulin action in humans appears to be a very early
metabolic maladaptation to inactivity that is sustained over the course of at least several
weeks of continued inactivity.

5.1

Metabolic response to inactivity versus exercise
Previous data on the regulation of lipoprotein lipase (LPL) activity suggest that

the underlying mechanism(s) and the magnitude of the metabolic response to inactivity
are not simply the opposite of the response to exercise (54). In the present study, the
decline in insulin action in response to inactivity (~18-39%) was similar in magnitude to
the increase in post-exercise insulin action observed in other studies (i.e. ~15-44%) (7,
67, 134). Thus, in contrast to LPL activity, it seems that the insulin action response to
inactivity closely mirrors the response to exercise, although the mechanisms underlying
those responses may be distinctly different. However, without direct comparisons
between the metabolic effects of exercise and inactivity on insulin action in the same
subject population, we cannot determine whether the magnitude of change in insulin
action is different in response to similar increases and decreases in energy expenditure.
Another novel aspect of the current study is the inactivity paradigm used.
Whereas previous studies in humans have mainly utilized bed rest as a model for
inactivity, we used a prolonged sitting protocol to experimentally reduce standing and
ambulation. Therefore, results from the present study are more relevant to the general
population who spend considerable portions of the waking day engaged in sedentary
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behaviors involving sitting (97). Recent epidemiological data suggest a positive
relationship between time spent in sedentary behaviors and risk for insulin resistance and
type 2 diabetes (35, 59, 60, 70). Results of this study provide additional evidence for a
strong, cause-and-effect relationship between sedentary behavior associated with sitting
and metabolic health outcomes reported in the epidemiological literature.

5.2

Mechanisms underlying inactivity-induced changes to insulin action
The mechanisms involved in the rapid, inactivity-induced decline in insulin action

are not well-characterized. Potential factors that could account for lower insulin action
following inactivity could involve reduced glucose transport, glucose oxidation and/or
storage (i.e. non-oxidative glucose disposal). Defects in insulin-stimulated glucose
disposal are often attributable to impaired non-oxidative glucose metabolism (16, 23,
118). Accordingly, several studies have reported selective impairments in glycogen
synthesis and insulin-mediated non-oxidative glucose disposal following inactivity (100,
131). However, compared to the active condition, non-oxidative glucose disposal did not
change following inactivity, suggesting that reduced insulin action in either of the
inactive conditions is not attributable to impaired glucose storage. Several studies have
reported a significant reduction in glucose transporters (GLUT-4) following inactivity
(138, 145), which has been directly related to the inactivity-induced decline in insulin
action (145). Although not measured in the present study, changes to glucose transport
capacity may therefore be a more plausible mechanism for the inactivity-induced decline
in insulin action. Other potential mechanisms are greater circulating levels of
counterregulatory hormones (e.g. glucagon, epinephrine, cortisol) (144), decreased
muscle blood flow (100), or increased systemic inflammation (11, 18). The data are
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inconsistent, however, as to whether any of these factors play a major role in the insulin
action response to inactivity. In summary, the diversity of findings suggests that the
mechanism to explain the reduction in insulin action in response to inactivity is
multifactorial and complex, but likely involves impaired glucose transport capacity.

5.3

Role of energy surplus on the insulin action response to inactivity
Considering the important effects of diet adds complexity to understanding the

effects of inactivity on insulin action. Data from Stettler et al. (135) highlighted the
importance of diet composition on whole-body insulin action following inactivity. In that
study, the inactivity-induced decline in insulin action was prevented when the proportion
of dietary fat was reduced from 45% to 15% of total calories. Results of the present study
expand upon prior research by emphasizing the importance of a previously unexplored
mechanism (i.e. energy surplus) on the metabolic response to inactivity. Holding
macronutrient composition constant, energy surplus accounted for 53% of the deleterious
effects of inactivity on insulin action. Taken together, these results suggest that energy
surplus plays a key role in the metabolic response to inactivity, although diet composition
may be important.
It is clear from studies in both animals (146) and humans (4, 52, 113) that energy
surplus elicits decrements in insulin action prior to significant changes in body weight. In
a previous study in our laboratory, insulin action was 30% lower after to 3 days of
overfeeding (i.e. energy surplus) (52) in active men and women. The independent effects
of energy surplus could not be determined since the 3-day overfeeding period was
coupled with a reduction in structured exercise (52). To our knowledge, the present study
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is the first to document the independent effect of energy surplus on insulin action when
activity/energy expenditure is carefully controlled.
Further, results from this study provide insight into the duration of the metabolic
response to energy surplus. No studies have examined the effects of energy surplus
lasting less than ~2 days; thus, it is unclear whether changes to insulin action occur in
response to acute (i.e. effect of the last meal) or more chronic changes to energy balance
(i.e. days). The study design used in the present study provides insight into this
uncertainty. To eliminate energy surplus during inactivity, we reduced the caloric content
of breakfast and lunch. However, we standardized the energy content of the evening meal
(i.e. 1030 kcals), temporarily restoring acute energy balance between conditions, which
may have minimized differences in insulin action. Remarkably, despite the equivalent
energy content of the evening meal, there were clear differences in insulin action between
the two inactive conditions. Therefore, the metabolic effect of a surplus of calories at
breakfast and lunch was sustained. While it is possible that a surplus of calories in the
evening meal could have augmented differences between the inactive conditions, these
results suggest that the metabolic response to energy surplus persists over the course of at
least one day (i.e. 24 hours).
When considering the separate effects of activity and energy status on insulin
action, only the effect of energy status was statistically significant. This result suggests
that energy status, rather than activity, has a stronger independent influence on wholebody insulin action. However, although not statistically significant, the effect of inactivity
per se is clearly physiologically relevant because inactivity independently accounted for
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47% of the decline in insulin action. Thus, it is presumptuous to conclude from these
results that energy status is more important than activity when both are clearly relevant.

5.4

Potential mechanisms involved in the metabolic response to inactivity and
insulin action
There are several potential mechanisms to explain lower insulin action in the

inactive, energy surplus condition. Non-oxidative glucose disposal was significantly
lower following inactivity with no change to diet compared to inactivity with reduced
energy intake. This observation provides evidence for impaired glucose storage as a
mechanism to explain the energy surplus-mediated reduction in insulin action. Although
not measured, differences in non-oxidative glucose disposal between the two inactive
conditions could be explained by differences in muscle glycogen stores. Although net
glycogen breakdown is negligible under conditions when demand for ATP is low (e.g.
during inactivity) (23), significantly greater carbohydrate intake in INACTIV compared
to INACTIV LO-CAL (426 g CHO vs. 280 g CHO) may have led to moderate, but
important increases in muscle glycogen content in INACTIV. Elevated muscle glycogen
levels would be expected to reduce insulin activation of glycogen synthase (15, 87, 94)
providing a potential mechanism to explain the lower insulin-mediated glucose disposal
following inactivity with no change to diet compared to inactivity with reduced energy
intake. However, without direct measurements of muscle glycogen and/or glycogen
synthase activity, we are unable to determine the mechanistic relationship between these
factors and our results.
Impaired insulin signaling to glucose transport could also account for lower
insulin-mediated glucose uptake following inactivity with no change to diet compared to

60

inactivity with reduced intake. Data from previous studies indicate that nutrient
oversupply of glucose and/or fatty acids impairs key components of the insulin signaling
pathway (50, 73, 81, 85, 88, 111, 115), potentially via upregulation of the hexosamine
biosynthetic pathway (111, 115); upregulation of inflammatory pathways (11, 49, 55)
and/or via accumulation of intracellular fatty acid moieties (81). In sum, multiple and
complex mechanisms are likely responsible for the significantly greater reduction in
insulin action following inactivity without change to energy intake.

5.5

Hepatic insulin action
Hepatic insulin action, as assessed by percent suppression of fasting hepatic

glucose production (HGP) by the glucose infusion, was not significantly different
between conditions. These results are consistent with studies showing that 7 days of bed
rest did not change hepatic insulin action in men (14, 100, 137). In contrast, Blanc et al.
(14) reported significant reductions in suppression of fasting hepatic glucose production
after 7 days of bed rest in women, suggesting a potential sex difference in the response to
inactivity. In the present study, although the pattern of the hepatic insulin action response
to inactivity was different in women versus men (23% increase vs. 5% increase,
respectively), these differences were not statistically significant. Although we may have
lacked sufficient power to detect differences, the existence of sex differences in hepatic
insulin action following inactivity in men versus women is dubious. Therefore, additional
research is warranted to determine whether there are distinct gender differences in the
response to inactivity and the mechanism to explain these differences.
The direction of the hepatic insulin action response was opposite to what we
anticipated. Numerically, hepatic insulin action was lowest in the active condition,
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highest following inactivity with no change to diet, and was intermediate following
inactivity with reduced energy intake. However, since glucose Ra and Rd are not
independent, less suppression of HGP (greater glucose production) in the active condition
could be explained by the higher glucose Rd. Nonetheless, our results support the general
finding that inactivity (lasting ≤ 7 days) has a negligible impact on hepatic insulin action,
in stark contrast to the large reduction to whole-body insulin action.

5.6

Metabolic flexibility and lipid metabolism
In addition to deleterious effects of inactivity on insulin action, several studies

also report detrimental effects of inactivity on lipid metabolism (8, 10, 155). For instance,
in rodents there are striking increases in postprandial TAG concentrations within 4-12
hours of hindlimb unloading. These changes are attributable to large (i.e. ≥ 50%)
reductions in lipoprotein lipase (LPL) activity (10, 53). In contrast to those previous
studies, we did not observe changes to lipid metabolism (i.e. insulin-mediated
suppression of lipolysis (∆ FFA), suppression of lipid oxidation (∆ LIPIDox)), after
inactivity with or without energy surplus. These results suggest these aspects of lipid
metabolism are relatively unaffected by 1 day of prolonged sitting. However, compared
to the active condition, fasting TAG concentrations 24 hours after the intervention were
greater in both inactive conditions (+27% INACTIV; +20% INACTIV LO-CAL),
although the difference was only statistically significant in the condition when diet was
not changed. In addition, the change in fasting TAG concentrations after the intervention
(i.e. O  2

O  1) was negligible in the inactive condition (+3 mg/dL, p=0.02) and in

the inactive, reduced energy intake condition (-4 mg/dL, p>0.05) compared to the active
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condition (-14 mg/dL). Bey et al. (10) also reported that fasting TAG concentrations did
not change after 12-18 hours of hindlimb unloading in rodents. Thus, these results
suggest that short-term (i.e. ≤ 24 hours) inactivity has little effect on fasting TAG
compared to the dramatic changes to postprandial TAG levels reported by Bey et al. (10).
Insulin resistance is often associated with metabolic inflexibility (i.e. impaired
“switching” from primarily lipid oxidation to primarily carbohydrate oxidation in
response to insulin stimulation (77)). Therefore, we hypothesized that the shift in the
respiratory exchange ratio (RER) from the fasting to insulin-stimulated state (∆RER)
would be blunted after 24 hours of inactivity. Despite a 22% lower ∆RER in both
inactive conditions compared to ACTIV, indicative of lower metabolic flexibility, these
differences were not statistically significant. Overall, these data suggest that 24 hours of
inactivity has more subtle effects on lipid metabolism (with the exception of the
postprandial lipid response) and metabolic flexibility compared with the larger changes to
whole-body insulin action.
In contrast, other studies employing longer-term inactivity protocols (i.e. days,
weeks) report significant decrements in markers of lipid metabolism (8, 14). For
example, Bergouignan et al. (8) reported a 37% increase in fasting TAG levels and an 8%
decrease in palmitate oxidation following one month of bed rest in healthy women. Blanc
et al. (14) reported even more dramatic reductions in fasting lipid oxidation (i.e. ~90%) in
response to a shorter period of bed rest (i.e. 7 days) in healthy women and men (14).
Thus, the majority of the detrimental effects of inactivity on lipid metabolism, metabolic
flexibility, and insulin-mediated suppression of lipolysis may take at least one week or
longer to manifest compared to the rapid effects of inactivity on insulin action.
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5.7

Importance of non-exercise activity on metabolic health
Epidemiological evidence to date indicates the importance of low-intensity, non-

exercise activities associated with daily living (e.g. standing, ambulating, household
chores, etc.) on metabolic health (59, 61, 70). An important finding of the present study
was the 20% reduction in fasting TAG levels in response to one day of high, non-exercise
activity. The magnitude of this change is similar to the ~30% reduction in fasting TAG
commonly reported following prolonged (i.e. ≥ 2 hours) of moderate exercise (27, 39, 47,
140). Interestingly, exercise duration appears to have a more potent effect on fasting
plasma TAG levels than exercise intensity when total energy expenditure is held constant
(24, 25, 80, 143). Data from the present study suggest that a sufficient quantity of lowintensity (i.e. < 4 METs) activities of daily living appears to lower fasting TAG as
effectively as a prolonged bout of moderate exercise. To our knowledge, this is the first
experimental study to provide direct evidence for a beneficial effect of high, non-exercise
activity on metabolic health.
Thus, data from the current study extend the findings from cross-sectional studies that the
health benefits of high daily energy expenditure on health can be gained via increases in
non-exercise activity.

5.8

Limitations and control for confounding variables
The use of healthy, normal-weight, active subjects may limit the generalizability

of the study results to the general population. We chose to study the metabolic response
to inactivity in recreationally-active, but not highly-trained, individuals to eliminate a
potential confounding impact of detraining on these responses. This population was also
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selected in order to minimize potential confounding effects of disease processes often
observed in overweight individuals who have low levels of physical activity.
Another limitation of the study is the short-term (24-hour) period of inactivity
since short-term metabolic adaptations to inactivity with concurrent energy surplus may
not be reflective of longer term changes to insulin action. Lack of significant changes to
lipid metabolism in response to 24 hours of inactivity certainly suggests this is true.
However, the decline in insulin action was similar in magnitude compared to other
studies that were longer in duration (90, 100, 133, 137). Further, compared to longer-term
studies, examining these responses over 24 hours was advantageous because it allowed
for greater control over study conditions and eliminated potential confounding factors
such as muscle atrophy and/or changes in body composition.
Energy balance and/or the amount of physical activity performed on the days
leading up to each 24-hour intervention may have influenced the response to inactivity.
To control energy balance, subjects were given all food to eat each day prior to the
intervention (i.e. Day -1). Based on estimated energy intake and expenditure, we
calculated energy balance for Day -1, which did not differ between conditions (p > 0.05).
Therefore, we are confident that energy balance on Day -1 did not impact the metabolic
response to the 24-hour protocol. To eliminate the potential confounding influence of
prior exercise, subjects were asked to refrain from structured exercise for 2 days prior to
each intervention. Based on activPal data, energy expenditure as well as total sitting,
standing, and stepping time on Day -1 were not different between conditions. Therefore,
prior physical activity had negligible impact on the response to inactivity.
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Finally, given the large differences in energy intake (~-1000 kcal/d) and similar
activPal data (i.e. total sitting and standing time) between the two inactive conditions we
are confident that, as designed, these two groups were in different energy states. It is
possible we may have underestimated energy expenditure in the active condition. Data
from Crouter et al. (26) indicate the metabolic equivalent of standing is less than what the
activPal software assumes (i.e. 1.19 vs. 2.0 MET/hr, respectively). If actual energy
expenditure was lower than estimated, differences in insulin action between the active
and inactive conditions would likely be minimized. However, the fact that we observed
such a large reduction in insulin action in the inactive versus active condition suggests
that our estimates approximated true energy expenditure. It is possible though that the
difference between energy intake and expenditure (i.e. energy balance) in the active
condition may have been larger than estimated (i.e. +162 ± 248 kcal/d), which could have
impacted our ability to detect significant differences in insulin action between this
condition and the inactive condition with reduced energy intake. If anything, the effect of
inactivity may be even larger than what we observed.

5.9

Summary and practical implications
In summary, results of this study are consistent with data from both animal (119,

131) and human (8, 14, 91, 100, 133) studies indicating the clear, deleterious effects of
inactivity on insulin action. However, our results extend these findings by implicating
the important role for energy surplus in the inactivity-induced decline in insulin action.
Thus, the detrimental effects of inactivity on insulin action can be minimized if energy
intake is reduced to match energy expenditure during inactivity. Still, 47% of the decline
in insulin action was not attributable to energy surplus suggesting that other mechanisms
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are involved in the process. Additional research is necessary to determine the cellular and
molecular mechanisms mediating the direct effect of inactivity on metabolism. Future
studies examining the mechanism for the reduction in insulin action following inactivity
should carefully control energy balance.
The dramatic reduction in insulin action within just one day of prolonged sitting
suggests the importance of maintaining daily non-exercise activity to minimize
detriments to metabolic health. In this regard, it may be prudent to develop public health
strategies aimed at limiting sitting and increasing daily non-exercise activity. Since
adults spend the majority of waking hours (i.e. > 90%) engaged in sedentary behaviors or
light-intensity activities (61), decreasing time spent sitting and/or increasing non-exercise
activities could substantially raise total daily energy expenditure and lead to improved
metabolic health (33, 54, 89, 97, 148).
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APPENDIX A
SCHEDULE OF ACTIVITIES DURING THE ACTIVE CONDITION

Arrival in
lab:

Hour
Hour 1

~8:00 AM

Hour 2
~9:00 AM

Hour 3
~10:00 AM

8 - 9 AM
Min
0:00-5:00
5:00-10:00
10:00-15:00
15:00-20:00
20:00-25:00
25:00-30:00
30:00-35:00
35:00-40:00
40:00-45:00
45:00-50:00
50:00-55:00
55:00-60:00

9-10 AM
0:00-5:00
5:00-10:00
10:00-15:00
15:00-20:00
20:00-25:00
25:00-30:00
30:00-35:00
35:00-40:00
40:00-45:00
45:00-50:00
50:00-55:00
55:00-60:00

10-11 AM
0:00-5:00
5:00-10:00
10:00-15:00
15:00-20:00
20:00-25:00
25:00-30:00
30:00-35:00
35:00-40:00

Sit and eat
Sit and eat
Sit and eat
Stand and eat
tidy up room
Dishes
sweep
fold laundry
walk to parking lot
walk
board games/cards
board games/cards

MET value
1.3
1.3
1.3
2
2.5
1.8
3
2.3
3.8
3.8
2
2

Avg.

2.26

work @ computer
work @ computer
work @ computer
work @ computer
vacuuming
vacuuming
board games/cards
board games/cards
board games/cards
Sit
Sit
Sit

2
2
2
2
3.5
3.5
2
2
2
1.3
1.3
1.3

Avg.

2.08

work @ computer
work @ computer
work @ computer
work @ computer
work @ computer
sweep
sweep
take out trash

2
2
2
2
2
3
3
3
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40:00-45:00
45:00-50:00
50:00-55:00
55:00-60:00

Hour 4
~11:00 AM

11 AM - 12 PM
0:00-5:00
5:00-10:00
0:00 - 15:00
15:00-20:00
20:00-25:00
25:00-30:00
30:00-35:00
35:00-40:00
40:00-45:00
45:00-50:00
50:00-55:00
55:00-60:00

tidy up room
Sit
Sit
Sit

3
1.3
1.3
1.3

Avg.

2.16

Sit
Sit
Sit
Stand
Stand
stand
stand
stand
dust
dust
vacuuming
vacuuming

1.3
1.3
1.3
2
2
2
2
2
2.4
2.4
3.5
3.5
2.14

Hour 5
~12:00 PM

12 PM - 1 PM
0:00-5:00
5:00-10:00
10:00-15:00
15:00-20:00
20:00-25:00
25:00-30:00
30:00-35:00
35:00-40:00
40:00-45:00
45:00-50:00
50:00-55:00
55:00-60:00

tidy up room
sit and eat
sit and eat
sit and eat
sit and eat
sit and eat
sit and eat
stand and eat
fold laundry
fold laundry
sweep
sweep

3
1.3
1.3
1.3
1.3
1.3
1.3
2
2.3
2.3
3
3
1.95

Hour 6
~1:00 PM

1-2 PM
0:00-5:00
5:00-10:00
10:00-15:00
15:00-20:00
20:00-25:00
25:00-30:00
30:00-35:00
35:00-40:00
40:00-45:00

work @ computer
work @ computer
work @ computer
work @ computer
work @ computer
work @ computer
work @ computer
vacuum
vacuum
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2
2
2
2
2
2
2
3.5
3.5

45:00-50:00
50:00-55:00
55:00-60:00

put away groceries
put away groceries
sweep

2.5
2.5
3
2.42

Hour 7
~ 2:00 PM

2-3 PM
0:00-5:00
5:00-10:00
10:00-15:00
15:00-20:00
20:00-25:00
25:00-30:00
30:00-35:00
35:00-40:00
40:00-45:00
45:00-50:00
50:00-55:00
55:00-60:00

sweep
tidy up room
tidy up room
work @ computer
work @ computer
darts
darts
darts
darts
darts
darts
darts

3
2.5
2.5
2
2
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.46

Hour 8
~ 3:00 PM

3-4 PM
0:00-5:00
5:00-10:00
10:00-15:00
15:00-20:00
20:00-25:00
25:00-30:00
30:00-35:00
35:00-40:00
40:00-45:00
45:00-50:00
50:00-55:00
55:00-60:00

stand
stand
vacuum
vacuum
darts
darts
darts
darts
darts
darts
darts
darts

2
2
3.5
3.5
2
2
2
2
2
2
2
2
2.25

Hour 9
~4:00 PM

4-5 PM
0:00-5:00
5:00-10:00
10:00-20:00
20:00-25:00
25:00-30:00
30:00-35:00
35:00-40:00
40:00-45:00
45:00-50:00
50:00-55:00

darts
darts
darts
darts
darts
darts
darts
darts
darts
Sit/catheter insertion
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2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
1.3

55:00-60:00

Sit

1.3
2.28

Hour 10
~5:00 PM

5-6 PM
0:00-5:00
5:00-10:00
10:00-15:00
15:00-20:00
20:00-25:00
25:00-30:00
30:00-35:00
35:00-40:00
40:00-45:00
45:00-50:00
50:00-55:00
55:00-60:00

sit and eat
sit and eat
sit and eat
sit and eat
stand and eat
stand and eat
work at computer
work at computer
work at computer
work at computer
work at computer
work at computer

1.3
1.3
1.3
1.3
2
2
2
2
2
2
2
2
1.77

Hour 11
~6:00 PM

6-7 PM
0:00-5:00
5:00-10:00
10:00-15:00
15:00-20:00
20:00-25:00
25:00-30:00
30:00-35:00
35:00-40:00
40:00-45:00
45:00-50:00
50:00-55:00
55:00-60:00

play games
play games
play games
play games
play games
play games
play games
play games
play games
walk
walk
Sit

2
2
2
2
2
2
2
2
2
3.8
3.8
1.3
2.24

Hour 12
~7:00 PM

7-8 PM
0:00-5:00
5:00-10:00
10:00-15:00
15:00-20:00
20:00-25:00
25:00-30:00
30:00-35:00
35:00-40:00
40:00-45:00
45:00-50:00
50:00-55:00
55:00-60:00

Sit
play games
play games
play games
play games
play games
play games
play games
play games
play games
Sit
Sit
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1.3
2
2
2
2
2
2
2
2
2
1.3
1.3

1.83

Hour 13
~8:00 PM

8-9 PM
0:00-5:00
5:00-10:00
10:00-15:00
15:00-20:00
20:00-25:00
25:00-30:00
30:00-35:00
35:00-40:00
40:00-45:00
45:00-50:00
50:00-55:00
55:00-60:00

walk outside
stand outside
stand outside
walk inside
work on computer
work on computer
work on computer
work on computer
work on computer
Sit
Sit
Sit

3.8
2
2
3.8
2
2
2
2
2
1.3
1.3
1.3
2.13

Hour 14
~9:00 PM

9-10 PM
0:00-5:00
5:00-10:00
10:00-15:00
15:00-20:00
20:00-25:00
25:00-30:00
30:00-35:00
35:00-40:00
40:00-45:00
45:00-50:00
50:00-55:00
55:00-60:00

Sit
Sit
Sit
play games
play games
play games
play games
play games
play games
play games
play games
play games

1.3
1.3
1.3
2
2
2
2
2
2
2
2
2
1.83

Hour 15
~10:00 PM

10-11 PM
0:00-5:00
5:00-10:00
10:00-15:00
15:00-20:00
20:00-25:00
25:00-30:00
30:00-35:00
35:00-40:00
40:00-45:00
45:00-50:00
50:00-55:00
55:00-60:00

sit
sit
sit
walk to bathroom
self care
self care
walk to lab
stand
stand
sit
sit
sit
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1.3
1.3
1.3
3.8
2
2
3.8
2
2
1.3
1.3
1.3

1.95

Hour 16
~11:00 PM

11-12 PM
0:00-5:00
5:00-10:00
10:00-15:00
15:00-20:00
20:00-25:00
25:00-30:00
30:00-35:00
35:00-40:00
40:00-45:00
45:00-50:00
50:00-55:00

play games
play games
play games
play games
Sit
Sit
Sit
Sit
Sit
Sit
Sit

2
2
2
2
1.3
1.3
1.3
1.3
1.3
1.3
1.3

55:00-60:00

Sit

1.3
1.53

Total AVG

2.08
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APPENDIX B
TABLES AND FIGURES
Table A.1 Energy balance and activPal data for Day -1 (M ± SD).
Sitting

Standing

Stepping

Sleep Time

Time (hrs)

Time (hrs)

Time (hrs)

(hrs)

Energy

Energy

Energy

Expenditure

Intake

Balance

(kcals/day)

(kcals/day)

(EI-EE)

10.1 ± 2.1

3.8 ± 1.9

1.5 ± 1.0

8.3 ± 1.9

2497 ± 438

2420 ± 478

-77 ± 277

INACTIV

9.6 ± 2.5

3.7 ± 1.6

1.5 ± 0.5

9.1 ± 2.0

2311 ± 456

2157 ± 455

-87 ± 164

INACTIV LO-CAL

10.7 ± 2.2

3.1 ± 1.6

1.6 ± 0.8

8.6 ± 1.1

2430 ± 450

2338 ± 493

-92 ± 145

74

ACTIV

Figure A.1 Relationship between energy balance on Day -1 and insulin action measured
24 hours following the intervention.
r2 = 0.05

Figure A.2 Relationship between energy balance during the 24-hour intervention (Day 1)
and insulin action measured the following morning.
r2 = 0.09
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Figure A.3 Relationship between energy content of the evening meal (% total daily
energy intake) during the 24-hour intervention (Day 1) and insulin action measured the
following morning.

r2 = 0.08
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Figure A.4 Insulin action (Rd/SSPI) across condition in men (a) and women (b).
a.

b.
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Figure A.5 Hepatic insulin action (% suppression fasting hepatic glucose production) in
men (a) and women (b).
a.

b.

78

BIBLIOGRAPHY

1.
Acheson KJ, Decombaz J, Piguet-Welsch C, Montigon F, Decarli B,
Bartholdi I, and Fern EB. Energy, protein, and substrate metabolism in simulated
microgravity. Am J Physiol 269: R252-260, 1995.
2.
Ainsworth BE, Haskell WL, Leon AS, Jacobs DR, Jr., Montoye HJ, Sallis JF,
and Paffenbarger RS, Jr. Compendium of physical activities: classification of energy
costs of human physical activities. Med Sci Sports Exerc 25: 71-80, 1993.
3.
Arciero PJ, Smith DL, and Calles-Escandon J. Effects of short-term inactivity
on glucose tolerance, energy expenditure, and blood flow in trained subjects. J Appl
Physiol 84: 1365-1373, 1998.
4.
Bachmann OP, Dahl DB, Brechtel K, Machann J, Haap M, Maier T,
Loviscach M, Stumvoll M, Claussen CD, Schick F, Haring HU, and Jacob S. Effects
of intravenous and dietary lipid challenge on intramyocellular lipid content and the
relation with insulin sensitivity in humans. Diabetes 50: 2579-2584, 2001.
5.
Baldwin KM, Herrick RE, and McCue SA. Substrate oxidation capacity in
rodent skeletal muscle: effects of exposure to zero gravity. J Appl Physiol 75: 2466-2470,
1993.
6.
Baron AD, Brechtel G, Wallace P, and Edelman SV. Rates and tissue sites of
non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol 255: E769774, 1988.
7.
Ben-Ezra V, Jankowski C, Kendrick K, and Nichols D. Effect of intensity and
energy expenditure on postexercise insulin responses in women. J Appl Physiol 79: 20292034, 1995.
8.
Bergouignan A, Trudel G, Simon C, Chopard A, Schoeller DA, Momken I,
Votruba SB, Desage M, Burdge GC, Gauquelin-Koch G, Normand S, and Blanc S.
Physical inactivity differentially alters dietary oleate and palmitate trafficking. Diabetes
58: 367-376, 2009.
9.
Bertrais S, Beyeme-Ondoua JP, Czernichow S, Galan P, Hercberg S, and
Oppert JM. Sedentary behaviors, physical activity, and metabolic syndrome in middleaged French subjects. Obes Res 13: 936-944, 2005.

79

10.
Bey L, Areiqat E, Sano A, and Hamilton MT. Reduced lipoprotein lipase
activity in postural skeletal muscle during aging. J Appl Physiol 91: 687-692, 2001.
11.
Biolo G, Agostini F, Simunic B, Sturma M, Torelli L, Preiser JC, DebyDupont G, Magni P, Strollo F, di Prampero P, Guarnieri G, Mekjavic IB, Pisot R,
and Narici MV. Positive energy balance is associated with accelerated muscle atrophy
and increased erythrocyte glutathione turnover during 5 wk of bed rest. Am J Clin Nutr
88: 950-958, 2008.
12.
Black SE, Mitchell E, Freedson PS, Chipkin SR, and Braun B. Improved
insulin action following short-term exercise training: role of energy and carbohydrate
balance. J Appl Physiol 99: 2285-2293, 2005.
13.
Blair SN, Kohl HW, 3rd, Paffenbarger RS, Jr., Clark DG, Cooper KH, and
Gibbons LW. Physical fitness and all-cause mortality. A prospective study of healthy
men and women. Jama 262: 2395-2401, 1989.
14.
Blanc S, Normand S, Pachiaudi C, Fortrat JO, Laville M, and Gharib C. Fuel
homeostasis during physical inactivity induced by bed rest. J Clin Endocrinol Metab 85:
2223-2233, 2000.
15.
Bogardus C, Lillioja S, Stone K, and Mott D. Correlation between muscle
glycogen synthase activity and in vivo insulin action in man. J Clin Invest 73: 1185-1190,
1984.
16.
Bokhari S, Emerson P, Israelian Z, Gupta A, and Meyer C. Metabolic fate of
plasma glucose during hyperglycemia in impaired glucose tolerance: evidence for further
early defects in the pathogenesis of type 2 diabetes. Am J Physiol Endocrinol Metab 296:
E440-444, 2009.
17.
Booth FW, Gordon SE, Carlson CJ, and Hamilton MT. Waging war on
modern chronic diseases: primary prevention through exercise biology. J Appl Physiol
88: 774-787, 2000.
18.
Bosutti A, Malaponte G, Zanetti M, Castellino P, Heer M, Guarnieri G, and
Biolo G. Calorie restriction modulates inactivity-induced changes in the inflammatory
markers C-reactive protein and pentraxin-3. J Clin Endocrinol Metab 93: 3226-3229,
2008.

80

19.
Bull F, Armstrong T, Dixon T, Ham S, Neiman A, and Pratt M. Physical
inactivity. In: Comparative Quantification of Health Risks: Global and Regional Burden
of Disease due to Selected Major Risk Factors, edited by Ezzati M, Lopez A, Rodgers A
and Murray C. Geneva: World Health Organization, 2003.
20.
Burchfiel CM, Reed DM, Marcus EB, Strong JP, and Hayashi T. Association
of diabetes mellitus with coronary atherosclerosis and myocardial lesions. An autopsy
study from the Honolulu Heart Program. Am J Epidemiol 137: 1328-1340, 1993.
21.
Burstein R, Polychronakos C, Toews CJ, MacDougall JD, Guyda HJ, and
Posner BI. Acute reversal of the enhanced insulin action in trained athletes. Association
with insulin receptor changes. Diabetes 34: 756-760, 1985.
22.
Chokkalingam K, Jewell K, Norton L, Littlewood J, van Loon LJ, Mansell P,
Macdonald IA, and Tsintzas K. High-fat/low-carbohydrate diet reduces insulinstimulated carbohydrate oxidation but stimulates nonoxidative glucose disposal in
humans: An important role for skeletal muscle pyruvate dehydrogenase kinase 4. J Clin
Endocrinol Metab 92: 284-292, 2007.
23.
Cline GW, Magnusson I, Rothman DL, Petersen KF, Laurent D, and
Shulman GI. Mechanism of impaired insulin-stimulated muscle glucose metabolism in
subjects with insulin-dependent diabetes mellitus. J Clin Invest 99: 2219-2224, 1997.
24.
Crouse SF, O'Brien BC, Grandjean PW, Lowe RC, Rohack JJ, Green JS,
and Tolson H. Training intensity, blood lipids, and apolipoproteins in men with high
cholesterol. J Appl Physiol 82: 270-277, 1997.
25.
Crouse SF, O'Brien BC, Rohack JJ, Lowe RC, Green JS, Tolson H, and
Reed JL. Changes in serum lipids and apolipoproteins after exercise in men with high
cholesterol: influence of intensity. J Appl Physiol 79: 279-286, 1995.
26.
Crouter SE, Churilla JR, and Bassett DR, Jr. Estimating energy expenditure
using accelerometers. Eur J Appl Physiol 98: 601-612, 2006.
27.
Cullinane E, Siconolfi S, Saritelli A, and Thompson PD. Acute decrease in
serum triglycerides with exercise: is there a threshold for an exercise effect? Metabolism
31: 844-847, 1982.

81

28.
Derave W, Hansen BF, Lund S, Kristiansen S, and Richter EA. Muscle
glycogen content affects insulin-stimulated glucose transport and protein kinase B
activity. Am J Physiol Endocrinol Metab 279: E947-E955, 2000.
29.
Devlin JT, Hirshman M, Horton ED, and Horton ES. Enhanced peripheral and
splanchnic insulin sensitivity in NIDDM men after single bout of exercise. Diabetes 36:
434-439, 1987.
30.
Devlin JT and Horton ES. Effects of prior high-intensity exercise on glucose
metabolism in normal and insulin-resistant men. Diabetes 34: 973-979, 1985.
31.
Diamond MP, Jacob R, Connolly-Diamond M, and DeFronzo RA. Glucose
metabolism during the menstrual cycle. Assessment with the euglycemic,
hyperinsulinemic clamp. J Reprod Med 38: 417-421, 1993.
32.
Dolkas CB and Greenleaf JE. Insulin and glucose responses during bed rest
with isotonic and isometric exercise. J Appl Physiol 43: 1033-1038, 1977.
33.
Donahoo WT, Levine JA, and Melanson EL. Variability in energy expenditure
and its components. Curr Opin Clin Nutr Metab Care 7: 599-605, 2004.
34.
Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak
LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, and Shulman GI. Effects
of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3kinase activity. J Clin Invest 103: 253-259, 1999.
35.
Dunstan DW, Salmon J, Healy GN, Shaw JE, Jolley D, Zimmet PZ, and
Owen N. Association of television viewing with fasting and 2-h postchallenge plasma
glucose levels in adults without diagnosed diabetes. Diabetes Care 30: 516-522, 2007.
36.
Dunstan DW, Salmon J, Owen N, Armstrong T, Zimmet PZ, Welborn TA,
Cameron AJ, Dwyer T, Jolley D, and Shaw JE. Associations of TV viewing and
physical activity with the metabolic syndrome in Australian adults. Diabetologia 48:
2254-2261, 2005.
37.
Dunstan DW, Salmon J, Owen N, Armstrong T, Zimmet PZ, Welborn TA,
Cameron AJ, Dwyer T, Jolley D, and Shaw JE. Physical activity and television
viewing in relation to risk of undiagnosed abnormal glucose metabolism in adults.
Diabetes Care 27: 2603-2609, 2004.

82

38.
Ekelund LG, Haskell WL, Johnson JL, Whaley FS, Criqui MH, and Sheps
DS. Physical fitness as a predictor of cardiovascular mortality in asymptomatic North
American men. The Lipid Research Clinics Mortality Follow-up Study. N Engl J Med
319: 1379-1384, 1988.
39.
Ferguson MA, Alderson NL, Trost SG, Essig DA, Burke JR, and Durstine
JL. Effects of four different single exercise sessions on lipids, lipoproteins, and
lipoprotein lipase. J Appl Physiol 85: 1169-1174, 1998.
40.
Ferrannini E, Barrett EJ, Bevilacqua S, and DeFronzo RA. Effect of fatty
acids on glucose production and utilization in man. J Clin Invest 72: 1737-1747, 1983.
41.
Ford ES, Kohl HW, 3rd, Mokdad AH, and Ajani UA. Sedentary behavior,
physical activity, and the metabolic syndrome among U.S. adults. Obes Res 13: 608-614,
2005.
42.
Frias JP, Macaraeg GB, Ofrecio J, Yu JG, Olefsky JM, and Kruszynska YT.
Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in
women. Diabetes 50: 1344-1350, 2001.
43.
Fulton-Kehoe D, Hamman RF, Baxter J, and Marshall J. A case-control study
of physical activity and non-insulin dependent diabetes mellitus (NIDDM). the San Luis
Valley Diabetes Study. Ann Epidemiol 11: 320-327, 2001.
44.
Garcia-Roves PM, Han DH, Song Z, Jones TE, Hucker KA, and Holloszy
JO. Prevention of glycogen supercompensation prolongs the increase in muscle GLUT4
after exercise. Am J Physiol Endocrinol Metab 285: E729-736, 2003.
45.
Gaudreault N, Santure M, Pitre M, Nadeau A, Marette A, and Bachelard H.
Effects of insulin on regional blood flow and glucose uptake in Wistar and SpragueDawley rats. Metabolism 50: 65-73, 2001.
46.
Gazdag AC, Wetter TJ, Davidson RT, Robinson KA, Buse MG, Yee AJ,
Turcotte LP, and Cartee GD. Lower calorie intake enhances muscle insulin action and
reduces hexosamine levels. Am j Physiol Regul Integr Comp Physiol 278: R504-R512,
2000.
47.
Gill JM, Herd SL, Tsetsonis NV, and Hardman AE. Are the reductions in
triacylglycerol and insulin levels after exercise related? Clin Sci (Lond) 102: 223-231,
2002.
83

48.
Grant PM, Ryan CG, Tigbe WW, and Granat MH. The validation of a novel
activity monitor in the measurement of posture and motion during everyday activities. Br
J Sports Med 40: 992-997, 2006.
49.
Gregor MG and Hotamisligil GS. Adipocyte stress: The endoplasmic reticulum
and metabolic disease. J Lipid Res, 2007.
50.
Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear
LJ, Kraegen EW, White MF, and Shulman GI. Free fatty acid-induced insulin
resistance is associated with activation of protein kinase C theta and alterations in the
insulin signaling cascade. Diabetes 48: 1270-1274, 1999.
51.
Gustat J, Srinivasan SR, Elkasabany A, and Berenson GS. Relation of selfrated measures of physical activity to multiple risk factors of insulin resistance syndrome
in young adults: the Bogalusa Heart Study. J Clin Epidemiol 55: 997-1006, 2002.
52.
Hagobian TA and Braun B. Interactions between energy surplus and short-term
exercise on glucose and insulin responses in healthy people with induced, mild insulin
insensitivity. Metabolism 55: 402-408, 2006.
53.
Hamilton MT, Hamilton DG, and Zderic TW. Exercise physiology versus
inactivity physiology: an essential concept for understanding lipoprotein lipase
regulation. Exerc Sport Sci Rev 32: 161-166, 2004.
54.
Hamilton MT, Hamilton DG, and Zderic TW. Role of low energy expenditure
and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease.
Diabetes 56: 2655-2667, 2007.
55.
Hamish Courtney C and Olefsky JM. Insulin Resistance. In: Mechanisms of
Insulin Action, edited by Saltiel AR and Pessin JE. Austin, TX: Landes Bioscience and
Springer Science + Business Media, 2007, p. 185-209.
56.
Haskell WL. J.B. Wolffe Memorial Lecture. Health consequences of physical
activity: understanding and challenges regarding dose-response. Med Sci Sports Exerc
26: 649-660, 1994.
57.
Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera
CA, Heath GW, Thompson PD, and Bauman A. Physical activity and public health:
updated recommendation for adults from the American College of Sports Medicine and
the American Heart Association. Med Sci Sports Exerc 39: 1423-1434, 2007.
84

58.
Hawkins M, Barzilai N, Liu R, Hu M, Chen W, and Rossetti L. Role of the
glucosamine pathway in fat-induced insulin resistance. J Clin Invest 99: 2173-2182,
1997.
59.
Healy GN, Dunstan DW, Salmon J, Cerin E, Shaw JE, Zimmet PZ, and
Owen N. Objectively measured light-intensity physical activity is independently
associated with 2-h plasma glucose. Diabetes Care 30: 1384-1389, 2007.
60.
Healy GN, Dunstan DW, Salmon J, Shaw JE, Zimmet PZ, and Owen N.
Television time and continuous metabolic risk in physically active adults. Med Sci Sports
Exerc 40: 639-645, 2008.
61.
Healy GN, Wijndaele K, Dunstan DW, Shaw JE, Salmon J, Zimmet PZ, and
Owen N. Objectively measured sedentary time, physical activity, and metabolic risk: the
Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Diabetes Care 31: 369-371,
2008.
62.
Heath GW, Gavin JR, 3rd, Hinderliter JM, Hagberg JM, Bloomfield SA, and
Holloszy JO. Effects of exercise and lack of exercise on glucose tolerance and insulin
sensitivity. J Appl Physiol 55: 512-517, 1983.
63.
Hebert LF, Jr., Daniels MC, Zhou J, Crook ED, Turner RK, Simmons ST,
Neidigh JL, Zhu JS, Baron AD, and McClain DA. Overexpression of
glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin
resistance. J Clin Invest 98: 930-936, 1996.
64.
Helmrich SP, Ragland DR, Leung RW, and Paffenbarger RS, Jr. Physical
activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J
Med 325: 147-152, 1991.
65.
Henriksen EJ, Bourey RE, Rodnick KJ, Koranyi L, Permutt MA, and
Holloszy JO. Glucose transporter protein content and glucose transport capacity in rat
skeletal muscles. Am J Physiol 259: E593-598, 1990.
66.
Hoffman AA, Nelson WR, and Goss FA. Effects of an exercise program on
plasma lipids of senior Air Force officers. Am J Cardiol 20: 516-524, 1967.
67.
Holtz KA, Stephens BR, Sharoff CG, Chipkin SR, and Braun B. The effect of
carbohydrate availability following exercise on whole-body insulin action. Appl Physiol
Nutr Metab 33: 946-956, 2008.
85

68.
Host HH, Hansen PA, Nolte LA, Chen MM, and Holloszy JO. Rapid reversal
of adaptive increases in muscle GLUT-4 and glucose transport capacity after training
cessation. J Appl Physiol 84: 798-802, 1998.
69.
Houmard JA, Hortobagyi T, Neufer PD, Johns RA, Fraser DD, Israel RG,
and Dohm GL. Training cessation does not alter GLUT-4 protein levels in human
skeletal muscle. J Appl Physiol 74: 776-781, 1993.
70.
Hu FB. Sedentary lifestyle and risk of obesity and type 2 diabetes. Lipids 38:
103-108, 2003.
71.
Hu FB, Li TY, Colditz GA, Willett WC, and Manson JE. Television watching
and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in
women. Jama 289: 1785-1791, 2003.
72.
Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, and
Willett WC. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J
Med 345: 790-797, 2001.
73.
Itani SI, Ruderman NB, Schmieder F, and Boden G. Lipid-induced insulin
resistance in human muscle is associated with changes in diacylglycerol, protein kinase
C, and IkappaB-alpha. Diabetes 51: 2005-2011, 2002.
74.
Ivy JL, Zderic TW, and Fogt DL. Prevention and treatment of non-insulindependent diabetes mellitus. Exerc Sport Sci Rev 27: 1-35, 1999.
75.
Kawanaka K, Tabata I, Katsuta S, and Higuchi M. Changes in insulinstimulated glucose transport and GLUT-4 protein in rat skeletal muscle after training. J
Appl Physiol 83: 2043-2047, 1997.
76.
Kelley DE, Goodpaster B, Wing RR, and Simoneau JA. Skeletal muscle fatty
acid metabolism in association with insulin resistance, obesity, and weight loss. Am J
Physiol 277: E1130-1141, 1999.
77.
Kelley DE and Mandarino LJ. Fuel selection in human skeletal muscle in
insulin resistance: a reexamination. Diabetes 49: 677-683, 2000.

86

78.
Kien CL and Ugrasbul F. Prediction of daily energy expenditure during a
feeding trial using measurements of resting energy expenditure, fat-free mass, or HarrisBenedict equations. Am J Clin Nutr 80: 876-880, 2004.
79.
King DS, Dalsky GP, Clutter WE, Young DA, Staten MA, Cryer PE, and
Holloszy JO. Effects of exercise and lack of exercise on insulin sensitivity and
responsiveness. J Appl Physiol 64: 1942-1946, 1988.
80.
Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB,
McCartney JS, Bales CW, Henes S, Samsa GP, Otvos JD, Kulkarni KR, and Slentz
CA. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med
347: 1483-1492, 2002.
81.
Krebs M and Roden M. Nutrient-induced insulin resistance in human skeletal
muscle. Curr Med Chem 11: 901-908, 2004.
82.
Kriska AM, LaPorte RE, Pettitt DJ, Charles MA, Nelson RG, Kuller LH,
Bennett PH, and Knowler WC. The association of physical activity with obesity, fat
distribution and glucose intolerance in Pima Indians. Diabetologia 36: 863-869, 1993.
83.
Kronenberg F, Pereira MA, Schmitz MK, Arnett DK, Evenson KR, Crapo
RO, Jensen RL, Burke GL, Sholinsky P, Ellison RC, and Hunt SC. Influence of
leisure time physical activity and television watching on atherosclerosis risk factors in the
NHLBI Family Heart Study. Atherosclerosis 153: 433-443, 2000.
84.
Kump DS and Booth FW. Alterations in insulin receptor signalling in the rat
epitrochlearis muscle upon cessation of voluntary exercise. J Physiol 562: 829-838, 2005.
85.
Kurowski TG, Lin Y, Luo Z, Tsichlis PN, Buse MG, Heydrick SJ, and
Ruderman NB. Hyperglycemia inhibits insulin activation of Akt/protein kinase B but
not phosphatidylinositol 3-kinase in rat skeletal muscle. Diabetes 48: 658-663, 1999.
86.
Larsen DE, Rising R, Ferraro RT, and Ravussin E. Spontaneous overfeeding
with a 'cafeteria diet' in men: effect on 24-hour energy expenditure and substrate
oxidation. Int J Obes 19: 331-337, 1995.
87.
Laurent D, Hundal RS, Dresner A, Price TB, Vogel SM, Petersen KF, and
Shulman GI. Mechanism of muscle glycogen autoregulation in humans. Am J Physiol
Endocrinol Metab 278: E663-668, 2000.

87

88.
Laybutt DR, Schmitz-Peiffer C, Saha AK, Ruderman NB, Biden TJ, and
Kraegen EW. Muscle lipid accumulation and protein kinase C activation in the insulinresistant chronically glucose-infused rat. Am J Physiol 277: E1070-1076, 1999.
89.
Levine JA, Lanningham-Foster LM, McCrady SK, Krizan AC, Olson LR,
Kane PH, Jensen MD, and Clark MM. Interindividual variation in posture allocation:
possible role in human obesity. Science 307: 584-586, 2005.
90.
Lipman RL, Raskin P, Love T, Triebwasser J, Lecocq FR, and Schnure JJ.
Glucose intolerance during decreased physical activity in man. Diabetes 21: 101-107,
1972.
91.
Lipton RB, Liao Y, Cao G, Cooper RS, and McGee D. Determinants of
incident non-insulin-dependent diabetes mellitus among blacks and whites in a national
sample. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 138: 826-839,
1993.
92.
Lovejoy JC, Windhauser MM, Rood JC, and de la Bretonne JA. Effect of a
controlled high-fat versus low-fat diet on insulin sensitivity and leptin levels in AfricanAmerican and Caucasian women. Metabolism 47: 1520-1524, 1998.
93.
Lynch J, Helmrich SP, Lakka TA, Kaplan GA, Cohen RD, Salonen R, and
Salonen JT. Moderately intense physical activities and high levels of cardiorespiratory
fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men.
Arch Intern Med 156: 1307-1314, 1996.
94.
Mandarino LJ, Wright KS, Verity LS, Nichols J, Bell JM, Kolterman OG,
and Beck-Nielsen H. Effects of insulin infusion on human skeletal muscle pyruvate
dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in
oxidative and nonoxidative glucose metabolism. J Clin Invest 80: 655-663, 1987.
95.
Manson JE, Nathan DM, Krolewski AS, Stampfer MJ, Willett WC, and
Hennekens CH. A prospective study of exercise and incidence of diabetes among US
male physicians. Jama 268: 63-67, 1992.
96.
Manson JE, Rimm EB, Stampfer MJ, Colditz GA, Willett WC, Krolewski
AS, Rosner B, Hennekens CH, and Speizer FE. Physical activity and incidence of noninsulin-dependent diabetes mellitus in women. Lancet 338: 774-778, 1991.

88

97.
Matthews CE, Chen KY, Freedson PS, Buchowski MS, Beech BM, Pate RR,
and Troiano RP. Amount of time spent in sedentary behaviors in the United States,
2003-2004. Am J Epidemiol 167: 875-881, 2008.
98.
Mayer-Davis EJ, D'Agostino R, Jr., Karter AJ, Haffner SM, Rewers MJ,
Saad M, and Bergman RN. Intensity and amount of physical activity in relation to
insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Jama 279: 669-674,
1998.
99.
McIntosh TS, Davis HM, and Matthews DE. A liquid chromatography-mass
spectrometry method to measure stable isotopic tracer enrichments of glycerol and
glucose in human serum. Anal Biochem 300: 163-169, 2002.
100. Mikines KJ, Richter EA, Dela F, and Galbo H. Seven days of bed rest decrease
insulin action on glucose uptake in leg and whole body. J Appl Physiol 70: 1245-1254,
1991.
101. Mikines KJ, Sonne B, Farrell PA, Tronier B, and Galbo H. Effect of physical
exercise on sensitivity and responsiveness to insulin in humans. Am J Physiol 254: E248259, 1988.
102. Mikines KJ, Sonne B, Farrell PA, Tronier B, and Galbo H. Effect of training
on the dose-response relationship for insulin action in men. J Appl Physiol 66: 695-703,
1989.
103. Minehira K, Vega N, Vidal H, Acheson K, and Tappy L. Effect of
carbohydrate overfeeding on whole body macronutrient metabolism and expression of
lipogenic enzymes in adipose tissue of lean and overweight humans. Int J Obes Relat
Metab Disord 28: 1291-1298, 2004.
104. Morris JN, Heady JA, Raffle PA, Roberts CG, and Parks JW. Coronary
heart-disease and physical activity of work. Lancet 265: 1111-1120; concl, 1953.
105. Morris JN, Heady JA, Raffle PA, Roberts CG, and Parks JW. Coronary
heart-disease and physical activity of work. Lancet 265: 1053-1057; contd, 1953.
106. Mott DM, Lillioja S, and Bogardus C. Overnutrition induced decrease in insulin
action for glucose storage: in vivo and in vitro in man. Metabolism 35: 160-165, 1986.

89

107. Must A, Spadano J, Coakley EH, Field AE, Colditz G, and Dietz WH. The
disease burden associated with overweight and obesity. Jama 282: 1523-1529, 1999.
108. Neufer PD. The effect of detraining and reduced training on the physiological
adaptations to aerobic exercise training. Sports Med 8: 302-320, 1989.
109. Nicholson WF, Watson PA, and Booth FW. Glucose uptake and glycogen
synthesis in muscles from immobilized limbs. J Appl Physiol 56: 431-435, 1984.
110. Nuutila P, Raitakari M, Laine H, Kirvela O, Takala T, Utriainen T,
Makimattila S, Pitkanen OP, Ruotsalainen U, Iida H, Knuuti J, and Yki-Jarvinen
H. Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies
using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission
tomography. J Clin Invest 97: 1741-1747, 1996.
111. Obici S and Rossetti L. Minireview: nutrient sensing and the regulation of
insulin action and energy balance. Endocrinology 144: 5172-5178, 2003.
112. Obici S, Wang J, Chowdury R, Feng Z, Siddhanta U, Morgan K, and
Rossetti L. Identification of a biochemical link between energy intake and energy
expenditure. J Clin Invest 109: 1599-1605, 2002.
113. Olefsky J, Crapo PA, Ginsberg H, and Reaven GM. Metabolic effects of
increased caloric intake in man. Metabolism 24: 495-503, 1975.
114. Olsen RH, Krogh-Madsen R, Thomsen C, Booth FW, and Pedersen BK.
Metabolic responses to reduced daily steps in healthy nonexercising men. Jama 299:
1261-1263, 2008.
115. Patti ME. Nutrient modulation of cellular insulin action. Ann N Y Acad Sci 892:
187-203, 1999.
116. Pawlson LG, Field JB, McCally M, Schmid PG, Bensy JJ, and Piemme TE.
Effect of two weeks of bed rest on glucose, insulin and human growth hormone levels in
response to glucose and arginine stimulation. Aerospace Med Assoc Preprints: 105-106,
1968.
117. Peronnet F and Massicotte D. Table of nonprotein respiratory quotient: an
update. Can J Sport Sci 16: 23-29, 1991.

90

118. Petersen KF, Hendler R, Price T, Perseghin G, Rothman DL, Held N,
Amatruda JM, and Shulman GI. 13C/31P NMR studies on the mechanism of insulin
resistance in obesity. Diabetes 47: 381-386, 1998.
119. Ploug T, Ohkuwa T, Handberg A, Vissing J, and Galbo H. Effect of
immobilization on glucose transport and glucose transporter expression in rat skeletal
muscle. Am J Physiol 268: E980-986, 1995.
120. Powell KE and Blair SN. The public health burdens of sedentary living habits:
theoretical but realistic estimates. Med Sci Sports Exerc 26: 851-856, 1994.
121. Raitakari M, Nuutila P, Ruotsalainen U, Laine H, Teras M, Iida H,
Makimattila S, Utriainen T, Oikonen V, Sipila H, Haaparanta M, Solin O, Wegelius
U, Knuuti J, and Yki-Jarvinen H. Evidence for dissociation of insulin stimulation of
blood flow and glucose uptake in human skeletal muscle: studies using [15O]H2O,
[18F]fluoro-2-deoxy-D-glucose, and positron emission tomography. Diabetes 45: 14711477, 1996.
122. Rasmussen BB, Holmback UC, Volpi E, Morio-Liondore B, Paddon-Jones D,
and Wolfe RR. Malonyl coenzyme A and the regulation of functional carnitine
palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle. J Clin Invest
110: 1687-1693, 2002.
123. Reaven GM. Insulin resistance, the insulin resistance syndrome, and
cardiovascular disease. Panminerva Med 47: 201-210, 2005.
124. Reynolds THt, Brozinick JT, Jr., Larkin LM, and Cushman SW. Transient
enhancement of GLUT-4 levels in rat epitrochlearis muscle after exercise training. J Appl
Physiol 88: 2240-2245, 2000.
125. Richter EA, Kiens B, Mizuno M, and Strange S. Insulin action in human thighs
after one-legged immobilization. J Appl Physiol 67: 19-23, 1989.
126. Rimbert V, Boirie Y, Bedu M, Hocquette JF, Ritz P, and Morio B. Muscle fat
oxidative capacity is not impaired by age but by physical inactivity: association with
insulin sensitivity. Faseb J 18: 737-739, 2004.
127. Ritz P, Acheson KJ, Gachon P, Vico L, Bernard JJ, Alexandre C, and
Beaufrere B. Energy and substrate metabolism during a 42-day bed-rest in a head-down
tilt position in humans. Eur J Appl Physiol Occup Physiol 78: 308-314, 1998.
91

128. Salmon J, Bauman A, Crawford D, Timperio A, and Owen N. The association
between television viewing and overweight among Australian adults participating in
varying levels of leisure-time physical activity. Int J Obes Relat Metab Disord 24: 600606, 2000.
129. Schwarz JM, Neese RA, Turner S, Dare D, and Hellerstein MK. Short-term
alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose
production, de novo lipogenesis, lipolysis, and whole-body fuel selection. J Clin Invest
96: 2735-2743, 1995.
130. Segal KR, Edano A, Abalos A, Albu J, Blando L, Tomas MB, and Pi-Sunyer
FX. Effect of exercise training on insulin sensitivity and glucose metabolism in lean,
obese, and diabetic men. J Appl Physiol 71: 2402-2411, 1991.
131. Seider MJ, Nicholson WF, and Booth FW. Insulin resistance for glucose
metabolism in disused soleus muscle of mice. Am J Physiol 242: E12-18, 1982.
132. Slentz CA, Houmard JA, and Kraus WE. Modest exercise prevents the
progressive disease associated with physical inactivity. Exerc Sport Sci Rev 35: 18-23,
2007.
133. Smorawinski J, Kaciuba-Uscilko H, Nazar K, Kubala P, Kaminska E,
Ziemba AW, Adrian J, and Greenleaf JE. Effects of three-day bed rest on metabolic,
hormonal and circulatory responses to an oral glucose load in endurance or strength
trained athletes and untrained subjects. J Physiol Pharmacol 51: 279-289, 2000.
134. Stephens BR, Sautter JM, Holtz KA, Sharoff CG, Chipkin SR, and Braun B.
Effect of timing of energy and carbohydrate replacement on post-exercise insulin action.
Appl Physiol Nutr Metab 32: 1139-1147, 2007.
135. Stettler R, Ith M, Acheson KJ, Decombaz J, Boesch C, Tappy L, and Binnert
C. Interaction between dietary lipids and physical inactivity on insulin sensitivity and on
intramyocellular lipids in healthy men. Diabetes Care 28: 1404-1409, 2005.
136. Storlien L, Oakes ND, and Kelley DE. Metabolic flexibility. Proc Nutr Soc 63:
363-368, 2004.
137. Stuart CA, Shangraw RE, Prince MJ, Peters EJ, and Wolfe RR. Bed-restinduced insulin resistance occurs primarily in muscle. Metabolism 37: 802-806, 1988.

92

138. Tabata I, Suzuki Y, Fukunaga T, Yokozeki T, Akima H, and Funato K.
Resistance training affects GLUT-4 content in skeletal muscle of humans after 19 days of
head-down bed rest. J Appl Physiol 86: 909-914, 1999.
139. Thiebaud D, DeFronzo RA, Jacot E, Golay A, Acheson K, Maeder E, Jequier
E, and Felber JP. Effect of long chain triglyceride infusion on glucose metabolism in
man. Metabolism 31: 1128-1136, 1982.
140. Thompson PD, Cullinane E, Henderson LO, and Herbert PN. Acute effects of
prolonged exercise on serum lipids. Metabolism 29: 662-665, 1980.
141. Thompson PD, Cullinane EM, Sady SP, Flynn MM, Chenevert CB, and
Herbert PN. High density lipoprotein metabolism in endurance athletes and sedentary
men. Circulation 84: 140-152, 1991.
142. Toth MJ, Sites CK, Eltabbakh GH, and Poehlman ET. Effect of menopausal
status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal
and early postmenopausal women. Diabetes Care 23: 801-806, 2000.
143. Tsetsonis NV and Hardman AE. Reduction in postprandial lipemia after
walking: influence of exercise intensity. Med Sci Sports Exerc 28: 1235-1242, 1996.
144. Vernikos-Danellis J, Leach CS, Winget CM, Goodwin AL, and Rambaut PC.
Changes in glucose, insulin, and growth hormone levels associated with bedrest. Aviat
Space Environ Med 47: 583-587, 1976.
145. Vukovich MD, Arciero PJ, Kohrt WM, Racette SB, Hansen PA, and Holloszy
JO. Changes in insulin action and GLUT-4 with 6 days of inactivity in endurance
runners. J Appl Physiol 80: 240-244, 1996.
146. Wang J, Obici S, Morgan K, Barzilai N, Feng Z, and Rossetti L. Overfeeding
rapidly induces leptin and insulin resistance. Diabetes 50: 2786-2791, 2001.
147. Wareham NJ. Epidemiological studies of physical activity and diabetes risk, and
implications for diabetes prevention. Appl Physiol Nutr Metab 32: 778-782, 2007.
148. Wareham NJ, Wong MY, and Day NE. Glucose intolerance and physical
inactivity: the relative importance of low habitual energy expenditure and
cardiorespiratory fitness. Am J Epidemiol 152: 132-139, 2000.

93

149. Wells L, Vosseller K, and Hart Gw. A role for N-acetylglucosamine as a
nutrient sensor and mediator of insulin resistance. Cell Mol Life Sci 60: 222-228, 2003.
150. Westerterp KR. Pattern and intensity of physical activity. Nature 410: 539,
2001.
151. Williams PT, Krauss RM, Wood PD, Lindgren FT, Giotas C, and Vranizan
KM. Lipoprotein subfractions of runners and sedentary men. Metabolism 35: 45-52,
1986.
152. Wood PD, Haskell WL, Stern MP, Lewis S, and Perry C. Plasma lipoprotein
distributions in male and female runners. Ann N Y Acad Sci 301: 748-763, 1977.
153. Yki-Jarvinen H. Insulin sensitivity during the menstrual cycle. J Clin Endocrinol
Metab 59: 350-353, 1984.
154. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK,
Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, and Shulman GI.
Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1
(IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277:
50230-50236, 2002.
155. Zderic TW and Hamilton MT. Physical inactivity amplifies the sensitivity of
skeletal muscle to the lipid-induced downregulation of lipoprotein lipase activity. J Appl
Physiol 100: 249-257, 2006.

94

